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 i 
Abstract 
 
 
The public health significance of campylobacters lies in their role as 
enteropathogens of man. Zoonotic in origin, they are the most commonly 
reported bacterial cause of gastrointestinal infection in the developed world. 
Approximately 46,000 laboratory-confirmed cases are reported annually in 
England and Wales, and this figure underestimates community disease by a 
factor of eight. Infection is unpleasant and, whilst self-limiting, a tenth of 
cases require hospital admission for their illness. Sequelae such Irritable 
Bowel Syndrome, Reactive Arthritis and Guillain-Barré Syndrome compound 
the problem. Despite the significant public health burden posed by 
campylobacters, our understanding of the epidemiology of Campylobacter 
infection is limited. This deficiency relates to a combination of the natural 
history of the microorganism, the high disease incidence which exists and the 
epidemiological tools applied thus far to its study. 
 
In order to gain a better understanding of the epidemiology of Campylobacter 
infection the Campylobacter Sentinel Surveillance Scheme was conceived in 
1998 and established in 1999. Through the integration of standardised 
epidemiological and microbiological data, it aimed to generate systematically 
new hypotheses for potential vehicles of infections, or transmission 
pathways, for campylobacteriosis. Twenty-two health authorities, 
representing all NHS regions at that time in England and in Wales and with a 
population of over 12 million people, participated in the study, which ran from 
May 2000 until April 2003.  
 
Standardised epidemiological data were captured on over 20,000 cases over 
the surveillance period and these were combined with microbiological data 
from detailed strain characterisation of patients‟ strains, referred at the same 
time. Case-case comparisons and disease determinant analysis were the 
epidemiological tools most commonly applied to the data. 
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The research carried out by the candidate demonstrated that age, gender, 
ethnicity, occupation and socioeconomic status are major determinants for 
Campylobacter infection in England and Wales, and that variation in 
behaviour throughout the week also has a bearing on risk.  It has shown that 
campylobacteriosis cannot be considered a single disease, as exposure 
differences exist in cases infected with different Campylobacter species or 
subspecies, and these differences can be confounded by foreign travel 
status. The fact that disease incidence amongst foreign travellers is country-
specific suggests that the above exposure differences will be confounded 
further by travel destination. It has shown that outbreaks of 
campylobacteriosis occur more commonly than described previously, 
suggesting that an opportunity for furthering our understanding of infection is 
being missed. Finally, the dose-response relationship for Campylobacter 
infection has been investigated, highlighting potential implications for the 
design of future epidemiological studies. 
 
Policy makers should be aware that future case-control studies of 
Campylobacter infection will need to be larger or more complex, and hence 
more costly. Such costs should be weighed against the opportunity for a 
more accurate assessment of disease risk, leading to improved evidence-
based policy development. Researchers should focus on assessing rapidly 
and by non-invasive means, previous exposure to campylobacters amongst 
healthy controls, improving further the accuracy of case-control studies, 
which remain the epidemiological method of choice for studying this disease. 
 
This study has demonstrated that the systematic collection of standardised 
epidemiological information on all cases of Campylobacter infection, reported 
from large, well defined populations over a prolonged period, coupled with 
detailed strain characterisation, can lead to public health gains. 
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1. Introduction. 
 
Campylobacters are small (0.3 to 0.6 μm in diameter) motile non-sporing 
Gram-negative comma-shaped rods belonging to the Proteobacteria phylum 
of bacteria (Skirrow, 1998). Whilst playing a role in periodontal disease, the 
main public health significance of campylobacters lies in their role as 
enteropathogens of man. Zoonotic in origin, campylobacters are the 
commonest bacterial cause of gastrointestinal infection in the developed 
world.  Some strains are prone to cause systemic infections (e.g. C. fetus) 
but these represent a minority of cases.  At least twelve species of 
Campylobacter have been linked with human infections, although C. jejuni 
and C. coli predominate in developed countries.  In developing countries 
campylobacters frequently cause diarrhoea-associated dehydration and 
malnutrition in infants and young children (Coker et al., 2002).  Here they are 
commonly isolated from healthy adults, suggesting immunity following 
childhood exposure, but with continued exposure in adult life. Other species 
are also more often prevalent, especially C. upsaliensis and, to a lesser 
extent, C. jejuni subsp. doylei. 
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2. History. 
 
In contrast to other common gastrointestinal pathogens, the history of 
campylobacters is comparatively short (detail provided in Appendix 1).  This 
relates largely to their exacting growth requirements (optimally 5-7% O2 and 
10% CO2 at 42-43°C) rather than a lack of interest in them or their recent 
emergence.  Indeed, campylobacters were probably first described in 1886 
by Theodore Escherich, who noted spiral bacteria in the intestinal mucus of 
infants who had died of „cholera infantum‟ (Kist, 1985).  However, he was 
unable to grow the organisms and considered their role to be prognostic 
rather than causative.  These findings, along with similar observations made 
by other German bacteriologists between 1887 and 1894, passed under the 
medical radar at the time as they were published in German, and interest 
waned due to a lack of culturability. 
 
Research into the veterinary aspects of Campylobacter infection continued, 
however, perhaps due to the economic impact of the microorganism in this 
setting.  Commissioned by the British Government to investigate epizootic 
abortion in cattle and sheep which was not infrequent at the time, 
McFadyean and Stockman were probably the first, in 1906, to isolate 
campylobacters from the uterine mucus of a pregnant sheep from a flock of 
ewes which was experiencing an abortion rate of 33% (Skirrow, 2006).  
Theodore Smith and colleagues were the first to describe vibrionic abortion in 
cattle in detail, to investigate their pathogenicity and to demonstrate their 
antigenic similarity (Smith, 1918; Smith & Taylor, 1919b; Smith, 1919; Smith, 
Little, & Taylor, 1920; Smith, 1923).  They noted that the foetus suffered 
secondarily as a result of increasing interference of the placental circulation 
by the microorganism, which they named Vibrio fetus.  
 
Attention then turned to the role of vibrios in diarrhoeal disease in animals.  
Through repeated washing, grinding, suspension and culture of intestinal 
mucosa, Jones, Orcutt and Little isolated, in 1931, tiny motile vibrios from 
cows and calves suffering from „epidemic winter scours‟ (Jones & Little, 
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1931a; Jones & Little, 1931b).  Demonstrating the absence of other 
potentially causative microorganisms, pathogenicity and antigenic-
relatedness which was distinct from the vibrios causing vibrionic abortion, 
they proposed along with Orcutt the name Vibrio jejuni to reflect the focus of 
infection (Jones, Orcutt, & Little, 1931).  Whilst investigating the cause of 
swine dysentery in 1944, Doyle noted that, of a number of organs tested, 
only the colonic wall from a diseased pig was capable of inducing disease 
when fed to susceptible pigs (Doyle, 1944).  He subsequently isolated vibrios 
from the colon of a dysenteric hog which was later termed Vibrio coli (Doyle, 
1948). 
 
Human diarrhoeal disease due to a vibrio was first reported by Levy in 1946 
(Levy, 1946).  Investigating a large outbreak of milkborne gastroenteritis 
affecting 357 inmates in two prisons in Illinois, he observed vibrio-like 
microorganisms in mucous from faeces submitted by acutely ill patients.  
Their significance was at first disregarded as they could not be cultured, 
however their presence in samples from 31 patients stimulated further study, 
and 16 of 306 stool samples taken three weeks into the outbreak were 
visually positive for the organism.  Morphologically-similar vibrios were 
isolated from blood samples from 13 of 39 patients, and were observed to 
resemble those of the V. fetus described by Smith, and more closely those of 
V. jejuni described by Jones and colleagues.  
 
The next major development occurred in 1957 and arose from combining 
findings from human and veterinary medicine.  Elizabeth King examined in 
detail the cultural, biochemical, and serological characteristics of 32 human 
and 13 veterinary vibrio isolates and compared these to the disease 
presentation and the available epidemiological information (King, 1957).  
These studies demonstrated the existence of a group of „related vibrios‟ 
which were physiologically (they grew best at 42°C) and antigenically distinct 
from V. fetus, and were prone to cause diarrhoeal disease in children, rather 
than the systemic or abortive disease caused by V. fetus in predisposed 
humans.  
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The application of veterinary techniques to human medicine was to provide 
the technical breakthrough which allowed the isolation of the bacteria from 
faeces.  Having isolated related vibrios from the blood of one of two linked 
cases of diarrhoea in Belgium in 1972, Jean-Paul Butzler approached a 
veterinary colleague for assistance in examining the patients‟ stool samples.  
Dekeyser diluted, homogenised and centrifuged the samples, and vibrios 
isolated from the filtered supernatants were antigenetically similar to each 
other and that from the blood sample (Dekeyser et al., 1972).  Examination of 
1000 „pathogen-negative‟ stool samples by this method resulted in the 
isolation of 35 strains of related vibrios, suggesting a significant role for these 
bacteria in the human gastrointestinal tract.  The following year Butzler 
extended this work by demonstrating that the pathogen was more prevalent 
in diseased children (5%) and adults (4%) than in children without diarrhoea 
(1.3%) (Butzler et al., 1973).  Inexplicably the findings of Dekeyser and 
Butzler did not receive the deserved attention, and it was not until Skirrow 
reported similar findings in the United Kingdom (UK) in 1977 that the 
importance of campylobacters was established (Skirrow ,1977). 
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3. The disease, its incidence and impact. 
 
As with many bacterial infections, the dose necessary for infection or illness 
is a product of the degree of exposure, the survivability and/or pathogenicity 
of the microorganism and the susceptibility/response of the host.  Information 
on the dose-response relationship for human Campylobacter infection is 
scant, with only one detailed study published.  Black and colleagues fed 
doses ranging from 102 to 109 organisms ml-1 to 111 adult volunteers and 
observed a dose-response relationship with infection but not illness, 
underlying the importance of host response (Black et al., 1988).  Another 
researcher developed symptoms and mounted an immune response after 
consuming 500 organisms in 180ml of milk (Robinson, 1981).  Recent 
modelling work combining data from the former feeding study above and two 
milkborne outbreaks suggests an exponential rather than linear dose-
response relationship (Teunis et al., 2005).   
 
The incubation period for Campylobacter infection is variable and difficult to 
establish, but review articles generally quote mean incubation periods of 
three days, ranging from eighteen hours to eight days (Skirrow & Blaser, 
2000), with an inversely proportional relationship between infective dose and 
incubation period (Skirrow, 1998; Blaser, 2000). Campylobacters which 
survive gastric transit multiply readily in the duodenum and jejunum, where 
they colonise the intestinal mucosa and adhere to intestinal cell surfaces 
(Ketley, 1997).  The normal absorptive capacity of the intestine is then 
disturbed by a combination of cell invasion, toxin production or activation of 
the immune response.  Laboratory-confirmed cases often experience 
prodromal symptoms of fever, headache, myalgia and malaise (Blaser, 
2000), with diarrhoea, malaise, abdominal pain and fever most common 
during the enteric phase.  Diarrhoea may range from loose stools to massive 
watery diarrhoea or grossly bloody stools, with patients experiencing more 
than ten episodes per day at the height of their illness.  
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The incidence of laboratory-confirmed cases of Campylobacter infection is 
provided in figure 1.  The increase in incidence between 1977 and ~1990 is 
largely an artefact of increasing interest in the pathogen and improvements in 
isolation. Nevertheless, campylobacters emerged as the most commonly 
reported bacterial cause of gastrointestinal disease in England and Wales in 
1984 - reports exceeding those for salmonellosis in that year. Incidence 
continued to increase throughout the 1990s and peaked in 2000 with almost 
58,000 cases reported.  Incidence then declined for a short period, but has 
increased again in the last two years, with over 46,000 cases reported in 
2006. 
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Figure 1. Campylobacter spp. Laboratory reports of faecal isolates reported 
to the Health Protection Agency Centre for Infections. England & Wales, 
1986-2006. 
 
A reporting pyramid for infectious intestinal disease (IID) exists in the UK, 
where decreasing proportions of community cases present to general 
practice, submit a stool specimen, have an aetiological agent identified 
successfully and have that result reported nationally. A Government-funded 
study (Food Standards Agency, 2000), conducted to assess this 
underestimation, found that for every laboratory-confirmed case of 
Campylobacter infection reported nationally there were 1.7 positive results, 
4.1 healthcare consultations and 8.7 community cases (Wheeler et al., 1999). 
Assuming these proportions remain unaltered, an estimated 405,000 
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Campylobacter infections would have occurred in England and Wales in 
2006, with 190,000 general practice consultations. The same study estimated 
that each case of Campylobacter infection cost the nation £315, based on 
1995 prices. Bringing these figures up to date (Anon., 2007), the cost of 
campylobacteriosis in England & Wales in 2006 would have been 
approximately £220,039,652.  
 
Campylobacter enteritis is usually self-limiting, with symptoms resolving 
gradually after the acute phase and lasting on average seven to ten days 
(Skirrow & Blaser, 2000).  A spectrum of illness exists, however, and almost 
ten percent of cases require hospital admission as a result of their illness.  
Infections can manifest extra-intestinally, most commonly as bacteraemia 
(Skirrow et al., 1993) and rarely as cholecystitis, pancreatitis, cystitis, 
meningitis and endocarditis (Peterson, 1994).  Irritable Bowel Syndrome and 
Reactive Arthritis are the most common sequelae associated with infection, 
occurring in 25% and 1-7% of cases respectively (Spiller et al., 2000; Hannu 
et al., 2002).  Less common but more serious, approximately one in 5000 
cases develop Guillain-Barré Syndrome – an acute demyelinating 
neuropathy, requiring months of intensive therapy (Tam et al., 2006b).  
 
Campylobacter-associated mortality is considered to be rare, but is relatively 
poorly described in the literature.  Scandinavian registry studies have 
demonstrated excess one year mortality following Campylobacter infection, 
suggesting that the long term impact of campylobacteriosis is 
underestimated. The same studies estimate case-fatality rates of 0.23% and 
0.19% respectively (Helms et al., 2003; Ternhag et al., 2005). To examine 
Campylobacter-associated mortality in England and Wales, mortality data 
from the Office for National Statistics were obtained and analysed (Appendix 
2).  Campylobacter infection was recorded as the underlying cause of death 
in 45 instances between 1993 and 2006, representing a case fatality rate of 
0.007%. However, when all causes of death were considered, 
campylobacters were implicated in 153 deaths (case fatality rate 0.02%), 
suggesting that the role of campylobacters in UK national mortality statistics 
is underestimated by a factor greater than three.  Most patients who died 
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were elderly or had a pre-existing underlying condition.  Over a quarter 
fulfilling both criteria.  Deaths were age and season-dependent, with mortality 
increasing in patients over 60 years and in the winter months. 
Campylobacter-associated mortality was most likely to be underestimated 
when the patient was very old (≥80 years) or had an underlying condition. 
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4. Campylobacter epidemiology: theory and practice. 
 
Despite the significant public health burden posed by campylobacters, our 
understanding of the epidemiology of Campylobacter infection is limited. This 
deficiency relates to a combination of the natural history of the 
microorganism, the high disease incidence which exists and the 
epidemiological tools applicable to its study. 
 
4.1 Outbreaks 
 
When conducted properly, the investigation of outbreaks of infection 
attributed to a specific pathogen can inform greatly on the epidemiology of 
disease caused by that pathogen (O'Brien et al., 2006).  Outbreaks are often 
defined as “an incident in which two or more people, thought to have a 
common exposure, experience a similar illness or proven infection (at least 
one of them being ill)” (Kessel et al., 2001).  Dissecting this definition into its 
component parts, it is clear why outbreaks of Campylobacter infection are 
rarely identified.  The long and variable incubation period for illness means 
that establishing accurately exposure amongst individuals and linking these 
exposures to those in others is problematic.  The low infective dose means 
that cross contamination plays an important role in disease transmission, 
hence the vehicle of infection may differ greatly from the source, and may not 
be recalled by the unaware victim.  The spectrum of illness caused by 
campylobacters and its effect on healthcare usage means that 
epidemiological links between community and laboratory-confirmed cases 
will rarely be established as the former will often be unknown to public health 
practitioners.  The lack of suitable routine laboratory subtyping methods for 
campylobacters means that the usual laboratory diagnosis of “Campylobacter 
species” lacks the sensitivity or specificity to identify microbiologically-linked 
cases from the background of sporadic cases.  Finally, the sheer number of 
infections reported mean that local investigators, who have only limited 
resources, do not follow up cases of Campylobacter infection as diligently as 
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they would for other bacterial gastrointestinal pathogens (Rooney et al., 
2000). 
 
4.2 Case-control studies 
 
Case-control studies are observational studies used frequently in infectious 
disease epidemiology.  They are relatively simple to plan and execute, and 
are particularly useful for rare diseases or those where other epidemiological 
approaches would be prohibitively expensive (e.g. cohort studies) or 
unethical (e.g. randomised control trials to investigate the potentially toxic 
effects of chemicals).  Fundamental to the case-control study is the 
establishment of an outcome of interest (e.g. confirmed infection, hospital 
admission, death etc) which distinguishes „cases‟ from „controls‟ within a 
particular study population.  Exposure information leading up to this outcome 
is then sought (either retrospectively or prospectively) for both cases and 
controls and appropriate statistical comparisons of these data are undertaken 
to identify factors particular to cases i.e. „risk factors‟ for the outcome of 
interest.   
 
Case-control studies are, however, subject to a number of biases which limit 
their effectiveness and have the potential to distort their findings.  Firstly, 
because they are identified through surveillance, cases usually include 
laboratory-confirmed infections who are selected non-randomly.  Infants, 
children and people with more severe/prolonged disease are more likely to 
present to and be seen by a primary care physician, and they may be more 
likely to submit a sample for laboratory testing.  Furthermore, laboratory-
confirmed cases might be more willing to participate in a study depending on 
their exposures, outcomes or both.  For example, patients who experienced a 
more severe illness might be more inclined to participate in a study than 
patients with milder infections, or they might be more assiduous in their 
responses to study questions.  Alternatively, patients who believe that they 
contracted their illness at a restaurant might be more willing to participate if 
they think that it might facilitate compensation claims against the 
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establishment.  Conversely controls, who represent the observed prevalence 
of exposure in the population if there was no association between that 
exposure and the outcome of interest, are selected at random from the 
population from which the cases arose, and hence are not subject to the 
same constraints. These differences, termed selection bias, may alter the 
findings of the study.  Differential recall bias may be introduced if cases (who 
have a „vested interest‟) are more conscientious in their responses than 
controls, and observer bias might be introduced if investigators, aware of the 
hypothesis under investigation, ask questions differently of cases and 
controls.  A major problem with case-control studies that use recruitment of 
laboratory-confirmed cases as their starting point is that the exposure window 
for cases might have been more than a month ago, whereas controls tend to 
answer questions about their exposure in the week or so prior to interview.  
Thus cases and controls are answering questions about exposure in 
completely different time periods.  
 
In order to assess the role of case-control studies in our understanding of 
Campylobacter infection, an analytical review of the scientific literature was 
undertaken (Appendix 3). Analysis of the titles and abstracts of 1734 
manuscripts, identified through interrogation of the PubMed database, 
revealed 36 potential case-control studies on sporadic human Campylobacter 
infection undertaken in developed countries (Murray, 1986; Deming et al., 
1987; Southern, Smith, & Palmer, 1990; Hudson et al., 1990; Lighton, 
Kaczmarski, & Jones, 1991; Hudson et al., 1991; Kapperud et al., 1992; 
McElroy & Smyth, 1993; Ikram et al., 1994; Schorr et al., 1994; Neal & Slack, 
1995; Adak et al., 1995; Neal et al., 1996; Eberhart-Phillips et al., 1997; Neal 
& Slack, 1997; Svenungsson et al., 2000; Studahl & Andersson, 2000; Effler 
et al., 2001; Rodrigues et al., 2001; Tenkate & Stafford, 2001; Smith et al., 
2002; Neimann et al., 2003; Kapperud et al., 2003; Potter, Kaneene, & Hall, 
2003; Evans, Ribeiro, & Salmon, 2003; Cameron et al., 2004; Friedman et 
al., 2004; Engberg et al., 2004; Schonberg-Norio et al., 2004; Michaud, 
Menard, & Arbeit, 2004; Carrique-Mas et al., 2005; Olesen et al., 2005; Baker 
et al., 2005; Ethelberg et al., 2005; Wingstrand et al., 2006; Fullerton et al., 
2007), with a further 27 articles identified through the reference lists of these 
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papers (Pearson et al., 1977; Bruce, Zochowski, & Ferguson, 1977; Blaser & 
Reller, 1981; Norkrans & Svedhem, 1982; Kist, 1982; Severin, 1982; Taylor 
et al., 1983; Hopkins & Scott, 1983; Blaser, Taylor, & Feldman, 1983; 
Santosham et al., 1983; Potter et al., 1983; Kist, 1983; Oosterom et al., 1983; 
Hopkins, Olmsted, & Istre, 1984; Oosterom et al., 1984; Engleberg et al., 
1984; Nolan, Harris, & Canova, 1984; Hopkins & Olmsted, 1985; Kist & 
Rossner, 1985b; Harris, Weiss, & Nolan, 1986; Harris et al., 1986; Harris, 
Weiss, & Thompson, 1986; Salfield & Pugh, 1987; Schmid et al., 1987; Harris 
et al., 1987; Saeed, Harris, & DiGiacomo, 1993; Kassenborg et al., 2004). 
Further scrutiny revealed eight were not case-control studies (Pearson et al., 
1977; Bruce, Zochowski, & Ferguson, 1977; Norkrans & Svedhem, 1982; 
Hopkins & Olmsted, 1985; Hudson et al., 1990; Svenungsson et al., 2000; 
Engberg et al., 2004; Olesen et al., 2005), four were case-case comparisons 
(Murray, 1986; Neal & Slack, 1995; Evans, Ribeiro, & Salmon, 2003; 
Kassenborg et al., 2004), three were non-exposure case-control studies 
(Neal et al., 1996; Smith et al., 2002; Ethelberg et al., 2005), three provided 
insufficient detail (Santosham et al., 1983; Kist, 1983; Baker et al., 2005), two 
were review articles (Blaser & Reller, 1981; Blaser, Taylor, & Feldman, 
1983), two described outbreaks of Campylobacter infection (Potter et al., 
1983; Harris et al., 1987), two were reports which went onto peer-reviewed 
publications which were included already (Oosterom et al., 1983; Nolan, 
Harris, & Canova, 1984) and one focussed on protective factors for 
Campylobacter infection (Cameron et al., 2004). One manuscript (Harris, 
Weiss, & Thompson, 1986) cited in the reference list of another (Saeed, 
Harris, & DiGiacomo, 1993) did not exist. These papers were excluded, and 
three papers (Harris, Weiss, & Nolan, 1986; Harris et al., 1986; Saeed, 
Harris, & DiGiacomo, 1993) reporting different aspects of the same study 
were combined into a single record, leaving 35 studies.  
 
Twelve studies were published in the 1980s, ten in the 1990s and thirteen to 
date this decade, with most studies conducted in North America, the United 
Kingdom (UK) and the rest of Europe in each of these decades respectively 
(table 1).  
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Table 1. Trends in the design and outcome of reported case-control studies 
of sporadic Campylobacter infection. 
 
Factor 
Decade (N) 
Total 
80s (12) 90s (10) 00s (13) 
Publication area (%)     
 N America 58 0 38 34 
 Rest of Europe 33 20 46 34 
 UK 8 60 8 23 
 Australasia 0 20 8 9 
Study population     
 All 75 80 77 77 
 Adults 17 20 0 11 
 Infants & children 8 0 23 11 
Percentage indigenous 9 40 62 38 
Mean study length (months) 14 7 12 11 
Mean sample size 326 456 565 452 
Mean number of variables 19 32 106 55 
Mean exposure period 7 10 10 9 
Mean interview lag 10 10 14 11 
Percentage matching 83 100 100 94 
Percentage multivariate analysis 17 50 92 54 
Foreign travel†     
 % enquiry 60 83 100 76 
 % risk factor 33 33 50 39 
Poultry variables     
 % enquiry – any 75 80 85 80 
 % enquiry – ch* 58 70 77 69 
 Mean no. variables – any 4 9 10 8 
 Mean no. variables – ch* 4 6 8 6 
 % risk factor – any 89 63 73 75 
 % risk factor – ch* 86 43 50 58 
Other (non-poultry) meats     
 % enquiry 42 70 92 69 
 Mean no. variables 8 5 6 6 
 % risk factor 40 29 42 38 
Dairy     
 % enquiry 40 100 100 80 
 % risk factor 80 51 31 46 
Water      
 % enquiry 42 60 77 60 
 % risk factor 80 33 40 48 
Animal contact     
 % enquiry 42 60 77 60 
 % risk factor 80 33 40 48 
Total risk factors identified 44 41 55 140 
Mean risk factors identified 4 4 4 4 
†
, Excludes indigenous-only studies; *, chicken 
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Studies were most frequently conducted over twelve months on subjects 
from all age groups, but some were restricted to adults or infants/children. 
The average number of study participants increased over the surveillance 
period, with the number of parameters under investigation increasing 
commensurately. Studies increasingly focused on indigenously-acquired 
infections, employed matching in control selection and utilised multivariate 
statistical techniques in analysis.  Surprisingly, the period of exposure for 
which information was sought did not vary greatly, averaging nine days. 
 
Based on the information reported, most studies asked participants about 
recent exposure to poultry (especially chicken) or dairy produce, as well as 
foreign travel and contact with animals and the wider environment. A 
disproportionately high number of questions on poultry and/or chicken 
consumption were included compared with other meat types, and the number 
of poultry-related questions posed increased over the surveillance period. 
The number of questions on selected epidemiological parameters, reported 
in each study, is provided in table A3.2 of Appendix 3. 
 
General poultry consumption was the most commonly identified risk factor, 
with three quarters (75%) of studies reporting this exposure where it was 
investigated, followed by animal contact (48%), water consumption (48%), 
dairy consumption (46%) and foreign travel (non-indigenous studies; 44%). 
Where investigated, chicken consumption was the most commonly identified 
specific exposure (58%), and the number of specific chicken risk factors 
reported (26) was exactly double the second most commonly reported 
specific risk factor (contact with animals other than dogs; 13; Appendix 3; 
table A3.3). Where Population Attributable Fractions (an estimate of the 
proportion of disease in the general population that is attributable to a 
particular risk factor) were reported (seven studies), chicken accounted for 
between 0 and 24% of campylobacter cases, and an average of 12% of 
cases. Other important specific risk factors identified included the 
consumption of unpasteurised milk (47%), barbecued food (44%) or raw 
water (44%), and contact with dogs (42%). No case-control studies identified 
beef or lamb as a risk factor for Campylobacter infection. 
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On average, four risk factors were identified in each study, with the number 
of factors ranging from one to twenty. Single variable Poisson regression 
analysis revealed that the number of risk factors identified in studies was 
unaffected by the decade in which it was undertaken, the area covered, or 
the duration of the study (Appendix 3; table A3.5). Limiting studies to 
indigenous cases, altering the exposure period, or applying multivariate 
statistical techniques in analysis also had no effect. However, the number of 
reported risk factors identified in studies was positively influenced by the 
number of cases or controls included in the study (and hence the overall 
study size), and the number of variables considered. Multivariable analysis 
controlling for study year demonstrated that only the number of controls 
included (Relative Risk (RR) 1.42; 95% Confidence Interval (CI) 1.03-1.94; 
P=0.031) and the number of variables investigated (RR 1.33; 95%CI 1.00-
1.77; P=0.048) were independently associated with the number of risk factors 
identified. 
 
There are two possible explanations for each of these associations. It is 
possible that an increase in the number of controls in the studies has 
increased the statistical power, making it possible to detect true risk 
differences which exist between cases and controls which had hitherto 
remained unidentified. However, if this was the case one would expect a 
synergistic effect with the number of cases in studies, but this was not 
observed, although it was noted that the case and control variables were 
highly correlated (coefficient 0.86; p<0.001) but not collinear. Alternatively, 
each control in a case-control study carries with them an inherent amount of 
bias, hence studies with more controls are reflecting increased bias between 
cases and controls rather than true differences in risk. Similarly, the inclusion 
of more questions might result in more answers, especially if the number of 
variables increases with study size. However, the number of variables and 
the study population were not strongly correlated (coefficient 0.37; p=0.07), 
suggesting the alternative explanation, that increasing the number of 
variables increases the occurrence of chance associations.  
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The content of peer-reviewed publications are influenced by editorial 
restrictions and researchers‟ perceptions of the most important aspects of 
their studies, and these factors might influence the analysis of data derived 
from published case-control studies. Nevertheless, the body of evidence 
available in the literature suggests that case-control studies of 
Campylobacter infection are increasing in size and complexity without the 
corresponding improvement in our understanding of disease transmission. If 
anything, the move towards larger studies is perhaps magnifying the biases 
inherent in the methodology. Furthermore, they appear to be influenced 
heavily by investigator and reporter bias, as evidenced by the 
disproportionate pursuit of the poultry hypothesis, which continues to explain 
only a fraction of cases.   
 
4.3 Case-case comparisons 
 
Case-case comparisons have been suggested as an alternative to case-
control studies for studying the epidemiology of infectious diseases 
(McCarthy & Giesecke, 1999).  These rely on comparing the exposures of 
one set of cases with those from another similar, but suitably different, set of 
cases.  These studies have a number of advantages.  Firstly, as the name 
suggests, there is no need to enrol healthy controls for comparison as the 
study consists wholly of cases.  This means that studies are not only easier 
to conduct (control selection and recruitment is often problematic and labour-
intensive) but there is also no need (in most instances) to obtain ethical 
approval if these studies are conducted within a primary surveillance 
framework. Indeed, this is a prerequisite in most instances, otherwise 
selection bias might occur.  Second, case-case studies have the potential to 
use all (or most) of the cases within a study population, meaning that any 
findings relate to the entire study population.  This does not usually occur in 
case-control studies, where only a small proportion of cases within a study 
population are used and the findings are (rightly or wrongly) extrapolated to 
the entire population.  Thirdly, assuming suitable groups of cases are 
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selected for comparison, it is unlikely that recall bias would differ between 
these groups, therefore differential recall bias will be minimised or removed.  
 
Case-case studies also have disadvantages. By definition, ill cases are not 
compared with healthy controls and therefore differences in exposure 
identified through such studies cannot be considered „risk factors‟ for 
infection in the classical sense.  Thus case-case comparisons can generate 
hypotheses for infection which require confirmation or refutation elsewhere.  
Similarly, it is not possible to make statements about the direction or 
magnitude of population risk based solely on the findings of case-case 
comparisons.  In a hypothetical example, both case group A and case group 
B reported exposure to X, and the level of exposure in group A was 
significantly higher than for group B, all other factors being equal.  The first 
impression is that exposure X was positively associated with group A.  
However, it might be equally possible that group B were significantly less 
likely to report exposure X than the „norm‟, hence the inflated association.  
Finally, case-case comparisons will not detect risk exposures common to the 
two groups of cases under comparison. 
 
4.4 Disease determinant analysis.  
 
 
A causal pathway is a theoretical depiction of the relationship between 
different factors which, alone or in combination, act to alter disease risk for an 
individual or population.  The term „pathway‟ is a misnomer to an extent, as it 
suggests a straightforward route „from a to b‟, whereas in reality causal 
pathways tend to exist more as frameworks, with some factors having a 
direct, or „proximal‟ effect, some having an intermediary effect and some 
have a more distant, or „distal‟ effect.  In an infectious disease context, a 
rather simplified example of such a pathway would be people of lower socio-
economic status (distal) within a particular developing country residing in 
poorer standard of housing (intermediary), hence having less access to 
treated water (proximal), which increases their risk of gastrointestinal 
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infection. An approximation of the likely distal and proximal factors applicable 
to Campylobacter infection in this study are shown in figure 2 below. 
 
Figure 2. Distal and proximal factors applicable to Campylobacter infection 
applicable to this study (illustrative rather than comprehensive). 
 
The assessment of the roles of different distal factors, or determinants, for a 
particular outcome is important in epidemiology, as the potential exists to 
exert control on that outcome further up the causal pathway.  To do so, a 
population with a particular outcome of interest (the numerator) must be 
observed and the distribution of the determinants measured, and this 
distribution compared with that for the underlying population (the 
denominator) from which the cases arose.  As with all epidemiological 
studies, such comparisons are prone to bias and must therefore be diligently 
designed and executed.  Central to this is the establishment of a population 
where all individuals with a particular outcome of interest would be easily 
identifiable, accessible and amenable to measurement, and where the 
population is sufficiently well-defined in that baseline measurements of 
suitable deterministic factors has already taken place. 
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5. Study aims and objectives. 
 
Given the sustained and significant public health impact of Campylobacter 
infection in England and Wales, the unsatisfactory understanding of its 
causes and consequences, and the apparent imperfections of the 
epidemiological tools thus far applied to its study, there was clearly a need 
for a new approach to the study of Campylobacter epidemiology.   
 
Reference typing methods for campylobacters were developed by the Public 
Health Laboratory Service (the forerunner to the Health Protection Agency) 
Campylobacter Reference Unit (CRU) between 1995 and 1997 and were 
piloted in the North West region and in Wales between 1998 and 1998. 
However, these areas were not representative of England and Wales as a 
whole and therefore a sentinel surveillance approach was required. 
 
The Campylobacter Sentinel Surveillance Scheme (CSSS) was conceived in 
1998, established in 1999 and ran from May 2000 until April 2003.  It was 
designed with three things in mind. Firstly, that the data accrued would be 
representative as described above. Secondly, that it would be of sufficient 
size to allow in-depth epidemiological analysis. Thirdly, that it would be 
designed around well defined populations to allow the calculation of robust 
incidence estimates. Twenty-two health authorities, representing all NHS 
regions in England and in Wales and with a population of over 12 million 
people, participated in the study, which aimed to capture data on 15% of all 
campylobacters reported annually (figure 3, overleaf). 
 
The study had two overall aims: to gain a better understanding of the 
epidemiology of Campylobacter infection and to generate systematically new 
hypotheses for potential vehicles of infection or transmission pathways for 
campylobacteriosis.  Both were to be achieved through the integration of 
standardised epidemiological and microbiological data generated through the 
scheme, and by the application of case-case methodology and disease 
determinant analysis to these data.  By its very nature, it was not possible to 
be more prescriptive about the aims of the study, as in order to generate new 
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hypotheses a „blank canvas‟ approach was necessary.  If aims were set 
based on existing knowledge then generating new hypotheses would have 
been problematic if not impossible. 
 
Figure 3. The health authorities (darker green) in England and Wales 
participating in the Campylobacter Sentinel Surveillance Scheme, by NHS 
region (black line). 
 
In order to accomplish these aims the following study objectives would need 
to be met: 
 
 To establish a working group for the project, including epidemiologists, 
microbiologists and statisticians, as well as representation from 
public/environmental health. 
 
 To develop a single study protocol, covering the epidemiological and 
microbiological aspects of the study and including sample size 
calculations. 
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 To recruit successfully Health Authorities in each of the NHS regions 
in England at that time (the Yorkshire and the Humber region has 
subsequently been split into two regions only one of which is 
represented) with a total population of approximately 12 million 
people. 
 
 To design a standard structured surveillance questionnaire amenable 
to use for a large number of cases over a three year period and to 
reach consensus on its content through dialogue with participants. 
 
 To set up a meeting with all participants to make them aware of what 
was expected for the project, to facilitate the smooth running of the 
scheme and to identify and solve potential difficulties prior to the start. 
 
 To design a database for the entry of data collected on the 
questionnaires and for the integration of the microbiological data. The 
database had to be robust enough to cope with the large amount of 
data which would be accrued and designed in such a way as to 
minimise the potential for error during the data entry process. 
 
 To design an analytical strategy and to apply this to data on a regular 
basis. To compile monthly, quarterly and annual surveillance reports, 
including assessments of response to the scheme by health authority 
as necessary. 
 
 To prepare articles for submission to peer-reviewed journals and to 
present findings at local, national and international conferences. 
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6. Materials and methods. 
 
Regional epidemiologists in England, and public health colleagues in Wales, 
were contacted in Autumn 1999 and invited to participate in the 
Campylobacter Sentinel Surveillance Scheme, which was due to commence 
in April of the following year. This invitation was disseminated to Health 
Authority-based Consultants in Disease Control, who then agreed or declined 
to participate. The following health authorities agreed to participate: 
 
 Yorkshire and the Humber 
o Bradford; Leeds 
 North West 
o Bury and Rochdale; Manchester; North Cumbria; North West 
Lancashire; Salford and Trafford; South Lancashire; Stockport; 
West Pennine; Wigan and Bolton 
 West Midlands 
o Birmingham; Herefordshire 
 East Midlands  
o Leicestershire; Nottingham 
 Eastern England 
o North Essex 
 London  
o Barnet, Enfield and Haringey 
 South East 
o East Kent; Southampton and South West Hampshire 
 South West 
o South and West Devon 
 Wales 
o Bro Taf; Dyfed Powys 
 
Each NHS region in England at that time was represented, although a 
greater proportion of health authorities in the north of the country were 
represented. The sentinel population was broadly representative of England 
and Wales as a whole (table 2, overleaf). The only major difference between 
health authorities which participated and those which did not was the degree 
of urbanisation, where a greater proportion of the sentinel population resided 
in less sparse urban areas. Indian and Pakistani communities were also 
slightly over-represented. 
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Table 2. Health Authorities participating in the Campylobacter Sentinel 
Surveillance Scheme population in relation to those in England and Wales as 
a whole. 
 
  Parameter 
Percent of population 
(unless stated otherwise) 
Sentinel  E&W
† Diff. 
          
Population  12.1 million‡ 52.0 million‡ - 
          
Age group       
  0-4 6 6 0 
  5-9 6 6 0 
  10-19 13 13 0 
  20-29 13 13 0 
  30-59 40 41 -1 
  60-64 5 5 0 
  65+ 16 16 0 
Ethnic group        
  White 89 91 -2 
  Black 2 2 0 
  Indian 3 2 1 
  Pakistani 3 1 2 
  Bangladeshi 1 1 0 
  Other Asian 0 0 0 
  Chinese 0 0 0 
  Mixed 1 1 0 
  Other 0 0 0 
Degree of urbanisation    
  Urban > 10K - Less Sparse 86 81 6 
  Urban > 10K - Sparse 0 0 0 
  Town and Fringe - Less Sparse 7 9 -2 
  Town and Fringe - Sparse 0 0 0 
  
Village, Hamlet & Isolated 
Dwellings – Less Sparse 6 9 -4 
  
Village, Hamlet & Isolated  
Dwellings – Sparse 1 1 0 
, Sentinel health Authorities; 
†
, England and Wales as a whole; 
‡
, persons 
 
The scheme was centred around a standard, structured clinical and exposure 
questionnaire (Appendix 4) was administered to each laboratory-confirmed 
case of Campylobacter infection in participating health authorities by public or 
environmental health personnel as part of the routine investigation of 
foodborne infection.  The questionnaire captured demographic and clinical 
information about the case, clinical details with regard to their illness 
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presentation and severity, foreign and UK travel, food consumption (~20 
questions relating to the main food groups), milk and water consumption, 
recreational water activity, contact with animals and contact with other ill 
people. Exposures related to the fourteen days prior to the onset of patients‟ 
illness. 
 
Collaborators formatted questionnaires as to their local style to encourage 
participation: the rationale being that individuals would prefer to receive a 
questionnaire from local teams rather than a national body. They were also 
permitted to add questions, if inclined, to answer specific research questions 
of their own, but could not to remove any, therefore maintaining the minimum 
dataset. Questionnaires were administered according to existing public or 
environmental practice, in that cases were contacted by post, by telephone or 
by personal visit depending on what method was currently in place. The 
study was piloted in two health authorities for one month prior to the start of 
the study and the effectiveness of the questionnaire as a surveillance tool 
was assessed at this time. 
 
Concurrently, campylobacter isolates from clinical microbiology laboratories 
within the health authority catchment areas were referred to the CRU for 
confirmation and characterisation (speciation (Bolton et al., 1992), serotyping 
(Frost et al., 1998), phage typing (Frost, Kramer, & Gillanders, 1999) and 
antimicrobial resistance testing (Thwaites & Frost, 1999).   
 
Electronic epidemiological and microbiological data were merged in Microsoft 
Access. The two datasets were linked initially using patient‟s surname and 
dates of birth. The forename, region and onset/specimen dates for linked 
cases were then compared in both datasets to ensure that the linkage was 
correct. For unlinked records a number of strategies were employed to 
identify the respective record in the other dataset. Searches of first name, 
date of birth and postcode were undertaken and the person details of 
potential matches compared. The first few letters of surnames and first 
names were analysed in the same way. Finally, for each case, the other 
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dataset was restricted to all cases of the same age, gender and region and 
the data were scanned to identify a potential match. The data were then  
classified in preparation for analysis.  
 
In each of the case-case comparison analyses, the effect of the exposures 
on the particular outcome of interest was investigated by single risk variable 
analysis using Stata statistical software (Stata Corporation, 1999). Two by 
two tables (larger for categorical variables) were constructed and Mantel-
Haenszel Odds Ratios (OR) were calculated along with confidence intervals 
and chi-squared significance tests. Exposures associated with the outcome 
of interest at a significance level greater than 90% (i.e. P<0.1 on chi-squared 
test) were selected for further investigation using multiple variable analysis. 
Initially, all variables were included in a single logistic regression model to 
obtain maximum likelihood estimates of the effect of each variable on the 
outcome of interest whilst controlling for the potential confounding effect of 
the other variables. The model was then simplified by stepwise exclusion: 
variables were removed sequentially from the model in order of least 
significance and tested for significance using the likelihood ratio test. This 
process was repeated until only significant (P<0.05) variables remained in 
the model. 
 
An analytical strategy for the case-case comparisons was developed through 
the study period. In the early work (papers 1 (Gillespie et al., 2003), 2 
(Gillespie et al., 2003) and 4 (Campylobacter Sentinel Surveillance Scheme 
Collaborators, 2002)), binary variables created to represent the different 
strata within distal factors were included in analyses with proximal factors. 
With hindsight this was far from ideal as the former, by definition, act 
indirectly on disease risk. Distal factors were ignored altogether in the sixth 
study (paper 6 (Gillespie et al., 2005)) and in the seventh study (paper 7 
(Gillespie et al., 2006)) a semi-hierarchical approach, as described by Victora 
and colleagues (Victora et al., 1997), was employed. This involved examining 
initially the effect of the distal measures on the outcome of interest, followed 
by separate analyses of the proximal measures from different transmission 
pathways (e.g. all the dairy variables together; all the water variables 
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together, etc). The results of the separate proximal analyses were then 
combined in a single logistic regression model which contained and retained 
the variables from the final distal model 
 
For the disease determinant analysis, appropriate denominator data were 
obtained from the Office for National Statistics (ONS).  Case data were than 
classified according to the particular classification schemes employed by the 
ONS and incidence calculated by comparing the case numerator with the 
population denominator for the different strata within the particular categories 
under investigation.  Relative risks with accompanying 95% confidence 
intervals and significance tests were calculated where required using Stata.  
Proportions and categorical proportions were compared using the chi-
squared test and the chi squared test for trend respectively, which were 
calculated using Epi Info (Dean et al., 1996). 
 
Further methodological considerations, particular to each study, are 
described in the following chapter. 
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7. Results. 
 
Study response rates. 
 
Between 1st May 2000 and 30th April 2003 28,730 isolates were referred for 
typing from 36 laboratories within the sentinel catchment area. For 1468 
isolates (5%) the bacterium referred was not Campylobacter spp. and for 389 
isolates (1%) it was not possible to resuscitate the referred bacterial culture. 
Additionally, during the spring peak of the second year of the study, 
reference laboratory workload was such that isolates were only typed if a 
questionnaire was received and therefore 176 isolates (0.6%) were not typed 
at this time. Therefore, 26,697 were available for study. 
 
During the same time period, 20,387 questionnaires were received from 21 
health authorities in England and Wales, giving an overall response rate of 
76% (table 3, overleaf). This response rate varied over the study period (74, 
86 and 69% respectively), with the best response observed in the second 
year of the study and a lower level in the final year. This feature is 
commonplace in studies of this kind, as there a lag whilst some health 
authorities/laboratories come on board at the start of a study and drop off 
towards the end of the study.  
 
Response rates also varied by health authority and within health authority by 
study year. This is partly a reflection of the phenomenon described above 
(East Kent being a good example here, where it took a year to convince the 
laboratories serving the population to participate), but also relates to the fact 
that health authorities and laboratories are not necessarily co-terminus, in 
that the referral of specimens for testing by general practitioners often relates 
more to economics than it does to geography. Therefore isolates from non-
sentinel health authority residents will have been referred and specimens 
from sentinel health authority residents will have been referred to non-
participating laboratories for testing. Whilst every effort was made to monitor 
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and improve response during the study period, this latter effect was beyond 
control. 
 
Table 3. Response rates by health authority over the surveillance period. 
 
Health Authority 
Question- 
naires 
Isolates 
Response 
(%)  
Response by 
study year 
1 2 3 
Barnet Enfield and 
Haringey 
510 206 248 95 270 470 
Birmingham 2007 2829 71 74 71 67 
Bradford 1079 200 540 214 ∞ ∞ 
Bro Taf 537 1245 43 0 108 50 
North Cumbria 0 682 0 0 0 0 
Dyfed Powys 104 587 18 31 16 0 
East Kent 684 1082 63 9800 40 32 
Hereford 386 150 257 86 ∞ ∞ 
Lancashire† 1264 2669 47 40 56 50 
Leeds 2084 3307 63 67 64 57 
Leicester 1255 1464 86 109 87 62 
Manchester‡ 4780 4613 104 89 122 112 
North Devon 1027 1823 56 59 66 42 
North Essex 1181 1506 78 69 92 75 
Nottingham 1872 2541 74 73 85 62 
Southampton and south 
west Hampshire 
1617 1793 90 102 108 54 
Total 20387 26697 76 74 86 69 
*
, Questionnaires received as a percentage of isolates referred; 
†
,North West and South Lancashire health 
authorities; 
‡
, Bury and Rochdale,  Manchester, Salford and Trafford,  Stockport, West Pennine & Wigan and Bolton 
health authorities. 
 
Figure 4 overleaf shows the age distribution of cases where isolates were 
received and questionnaires referred. Whilst the two datasets appear to be 
generally comparable, some subtle differences are apparent. Young adults 
were under represented amongst the questionnaire data and the opposite is 
true for older adults and the elderly. The latter reflects the fact that this age 
group is notoriously difficult to recruit into epidemiological studies. At the 
other end of the spectrum, older people may be retired and therefore have 
more free time to complete and return questionnaires. 
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Figure 4. The age distribution of cases where isolates were received and 
questionnaires referred. 
 
Linkage. 
 
Of 20,387 cases where a questionnaire was received it was possible to 
integrate typing data in 14,383 instances (71%). Linkage was done in this 
direction as the questionnaires could be guaranteed to be from residents of 
the sentinel health authorities. Closer scrutiny of these data, however, 
revealed that in 116 instances (0.6%) the linked individuals were not identical 
(different spellings of first names; different postcodes etc) and in 382 
instances (1.9%) the two records were not coincident in time (for 82 cases 
the specimen date occurred before the onset date and for 300 cases the 
specimen data was more than 28 days after the onset date). These records 
were considered unlinked in analyses involving linked data. 
 
Cases with linked data were no different to unlinked cases in terms of age 
(mean 39.4 years in both groups) or gender (68 and 69% linkage in males 
and females respectively) and linkage did not differ greatly across ethnic 
groups. The only exception to this was cases who described their ethnicity as 
„Other Asian‟ or „Other‟, where linkage was 65 and 50% respectively 
compared to 68% in other ethnic groups. These cases only accounted for 2% 
of all cases however. 
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The published work. 
 
7.1 Epidemiological distinctions between cases of Campylobacter jejuni 
and Campylobacter coli infection. 
 
Standard isolation methods for campylobacters currently used by clinical 
microbiology laboratories in England and Wales do not differentiate the 
species within the Campylobacter genus.  This is achieved through additional 
serological and biochemical testing, which is beyond the remit of routine 
public health microbiology.  Campylobacters are therefore generally reported 
to national surveillance as „Campylobacter species‟ and, as a result, are often 
considered by investigators to be a single disease.  This militates against 
understanding the epidemiology of individual Campylobacter species, as 
species-specific risk factors for infection might be obscured in an 
epidemiological study conducted at the genera level i.e. if a „risk factor‟ for 
one species is a „protective factor‟ for another.   
 
In order to assess this assumption, the exposures of 272 cases infected with 
C. coli (the second most common Campylobacter species, accounting for 
~8% of isolations or an estimated 3700 laboratory-confirmed cases reported 
annually) and 3489 cases infected with C. jejuni (the most common species, 
accounting for ~90% of isolations, or an estimated 41,600 laboratory-
confirmed cases reported annually) were therefore compared to identify 
epidemiological differences between the two species and to inform case 
definitions for future studies (paper 1 (Gillespie et al., 2002)).   
 
Although cases were similar clinically, a number of epidemiological 
differences were identified.  Cases infected with C. coli tended to be older 
than those with C. jejuni and were more likely to be of Asian ethnicity.  Travel 
abroad was important for infection with C. coli, as was the consumption of 
certain meats and bottled water.  A number of interactions between variables 
were observed, giving an indication of the complexity of the epidemiology in 
different demographic groups and at different times of the year.   
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This study demonstrated for the first time that the epidemiology of C. coli 
infection in humans differed significantly from C. jejuni infection.  A major 
implication was that future epidemiological studies of Campylobacter 
infection should be undertaken at the species level.  This also meant that 
subsequent case-case studies within the CSSS would also have to be 
restricted in this manner. 
 
7.2 Outbreak underascertainment in Campylobacter jejuni infection and 
hypotheses for their cause. 
 
As described above, despite a high disease incidence, outbreaks of 
Campylobacter infection are rare.  For example, of 297,511 laboratory-
confirmed cases of Campylobacter infection reported in England & Wales 
between 2000 and 2005 only 280 were reported as part of outbreaks (0.1%) 
(Health Protection Agency, unpublished data).  This compares with 6% for 
Salmonella infection and 12% for Vero cytotoxin-producing Escherichia coli 
O157 infection for the same period.  
 
In addition to capturing data on the patient, the CSSS questionnaire also 
enquired about other known individuals, either in the cases‟ household or in 
the surrounding community, who experienced similar symptoms at the same 
time as the index case.  These data were examined to investigate whether 
apparent family or community outbreaks of C. jejuni infection occur more 
frequently than is currently recognised, and to identify factors which might 
instigate them (paper 2 (Gillespie et al., 2003)).   
 
Seventeen percent (509/3489) of C. jejuni infection cases reported other 
illness in the household and 10% (333/3489) reported other illness in the 
community.  The primary cases in these groups were 465 and 323 
respectively, emphasising the comparatively low level of secondary 
transmission observed in campylobacteriosis (Friedman et al., 2000).  
Household illness was more common amongst cases reporting contact with 
diarrhoeal pets, visiting farms and consuming organic meats, whilst 
 46 
community illness was more common amongst patients reporting the 
consumption of unpasteurised milk or foods from restaurants.  
 
A limitation in this study was that household or community illness was not 
confirmed microbiologically and so these episodes might have been 
unconnected to cases‟ illness, leading to „false positive‟ clusters.  
Alternatively, cases might have been part of genuine clusters but were 
unaware of this, resulting in „false negatives‟.  With these caveats in mind, 
however, this study demonstrated that point source outbreaks of 
Campylobacter infection might be more common than previously thought and 
that better methods for outbreak detection are required.  Until suitable 
subtyping methods applicable to all campylobacters are developed, this 
might best be achieved through web-based collection of a standardised 
minimum surveillance dataset for all cases, allowing rapid identification and 
communication of clusters to local public/environmental health staff for further 
investigation. 
 
7.3 Destination-specific risk in travel-associated Campylobacter 
infection. 
 
Foreign travel is a major risk factor for gastrointestinal infection as a whole, 
and Campylobacter infection is no exception (Kist & Rossner, 1985b; Neal & 
Slack, 1997; Wingstrand et al., 2006).  However, foreign travel is greatly 
underestimated by laboratory surveillance, making it difficult to establish the 
true burden of travel-associated infections in the UK. This is important from a 
food safety policy perspective, as Governments need to be able to 
distinguish imported infections from those preventable through measures 
taken in their own countries.  Furthermore, booking a holiday or trip abroad 
does not alter disease risk in itself: activities undertaken whilst travelling have 
this effect. At the most basic level, the choice of destination can have a major 
effect on disease risk, and the identification of high risk travel destinations is 
therefore important for providing appropriate travel advice and for 
establishing an evidence base for policy development.   
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Travel destinations for cases reporting recent travel outside the UK were 
therefore classified according the ONS International Passenger Survey and 
destination-specific risks were calculated (paper 3 (Campylobacter Sentinel 
Surveillance Scheme Collaborators, 2003b)). In order to assess the effect of 
travel within the UK, the destinations for cases reporting within-UK travel 
were coded according to the ONS UK tourism survey and analysed in the 
same manner.  
 
In the first year of the study a fifth of campylobacter cases reported recent 
foreign travel (1444/7360; 20%), a smaller proportion (951; 13%) reported UK 
travel and 94 cases (1%) reported both.  Travel to the Indian subcontinent, to 
other parts of Asia and to the Pacific islands posed the greatest risk of 
infection, although in terms of impact, the increased risk associated with 
travel to Spain was of concern due to the large number of UK travellers to 
this destination.  Linked epidemiological and microbiological data 
demonstrated that C. coli infection was more often associated with foreign 
travel than infection with C. jejuni, and that travel to the Indian subcontinent 
posed a particular risk for this pathogen, perhaps explaining the association 
between C. coli and Asian ethnicity described previously (paper 1 (Gillespie 
et al., 2002)).  The risk of campylobacteriosis associated with travel within the 
UK was comparable with travel to a number of northern European 
destinations, although travel to Cumbria appeared to double the risk 
compared to other UK destinations. 
 
This study confirmed that foreign travel is an important determinant for 
Campylobacter infection and that the travel destination is also important. 
However, just as buying an airline ticket does not confer Campylobacter 
infection on an individual, nor does arriving at a particular destination, hence 
additional studies are required to quantify the within-country risk.  Given the 
adverse effect of negative publicity accompanying „holidays from hell‟, the 
high level of accessibility to both ill and well travellers and the legal 
responsibility for passenger safety, such studies should perhaps be the 
responsibility of the tourist industry.  The increased risk associated with travel 
to Cumbria might be an artefact of the large number of study collaborators in 
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north west England and in Yorkshire, and underlies the importance of 
obtaining appropriate denominator data for this type of analysis.  However, 
UK travel data were only available for the whole of England and Wales at the 
time of the study. 
 
7.4 Factors associated with the acquisition of ciprofloxacin-resistance 
Campylobacter jejuni infection at home and abroad. 
 
Like most gastrointestinal pathogens, illness with campylobacters is usually 
self limiting.  Symptoms resolve usually without specific medical intervention 
other than fluid replacement and electrolyte balance.  However, there are 
instances (for example, for patients with high fever, bloody diarrhoea or 
prolonged illness) where antimicrobial chemotherapy is indicated and 
erythromycin is usually the drug of choice.  The introduction of 
fluoroquinolones provided a useful alternative for adults with gastrointestinal 
illness, due to its activity against most enteric pathogens and its lack of side-
effects compared with erythromycin.  However, the emergence of 
fluoroquinolone resistance is a major public health problem worldwide 
(Bowler & Day, 1992; Piddock, 1995; Endtz et al., 1991).   
 
Exposure data for cases infected with ciprofloxacin-resistant strains of C. 
jejuni were therefore compared with those from cases with sensitive strains in 
order to identify factors which might lead to acquisition of ciprofloxacin-
resistant strains (paper 4 (Campylobacter Sentinel Surveillance Scheme 
Collaborators, 2002)).  An initial analysis demonstrated that cases who had 
travelled abroad were over five times more likely to be infected with 
ciprofloxacin-resistant strains than patients who had not travelled abroad.  
Since this difference was unlikely to have occurred by chance, foreign travel 
appeared to be an important risk factor for ciprofloxacin resistance, and 
hence analysis were restricted by foreign travel status.   
 
Amongst travel-associated cases (N=653), those infected with ciprofloxacin-
resistant strains were more likely to have travelled to specific destinations 
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(the Iberian peninsula and Cyprus) and were more likely to have eaten 
chicken or drunk bottled water than cases infected with fully sensitive strains. 
In cases who acquired their infection in the UK, ciprofloxacin resistance was 
more common amongst cases reporting the consumption of cold meats.   
 
This study has several important implications.  Firstly, if clinicians wish to 
treat a case of Campylobacter infection empirically with antibiotics it is 
important to obtain a travel history, since ciprofloxacin might be ineffective for 
patients returning from certain foreign destinations.  Secondly, self treatment 
of traveller‟s diarrhoea with over-the-counter ciprofloxacin might be 
unsuccessful.  This study also reinforced the confounding effect of foreign 
travel, so that future analyses within the scheme should be restricted by 
travel status.  Finally, the fact that the epidemiology differed with foreign 
travel status has implications for control. 
 
7.5 The role of ethnicity in Campylobacter infection. 
 
The major recognised drivers for Campylobacter infection at the time of the 
CSSS were age, gender, season and degree of urbanisation (Skirrow, 1987; 
Tam, 2001). The role of ethnic origin in Campylobacter infection, however, 
had not been previously investigated, despite observed relationships 
between ethnicity and other communicable and non-communicable diseases 
in the UK.  In order to assess the role of ethnic origin as a determinant for 
Campylobacter infection in England and Wales, the distribution of the main 
ethnic groups amongst 5180 non travel-associated cases was compared with 
denominator data specific to the participating sentinel health authorities 
(paper 5 (Campylobacter Sentinel Surveillance Scheme Collaborators, 
2003a)).  Accompanying exposure data was also analysed in an attempt to 
further quantify the risk. 
 
Resident Pakistanis were at greater risk of Campylobacter infection 
compared with the resident White population, whilst the resident Black and 
Indian populations were at decreased risk. The risk in the Chinese 
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community was no different from other recognised ethnic groups, although 
the number of cases in this group was small. Pakistani cases tended to be 
male and under five year olds were over-represented . Pakistani cases older 
than one year were more likely to experience a longer illness and more often 
required hospital treatment than their White counterparts. The seasonality of 
infection also differed amongst resident Pakistanis, with more illness at the 
beginning and end of the calendar year.  A number of exposure differences 
between resident Pakistani and White cases were apparent. 
 
This study identified a distinct pattern of infection for Pakistanis resident in 
England and Wales which could not be explained by recent foreign travel to 
high-incidence destinations as described previously (paper 3 
(Campylobacter Sentinel Surveillance Scheme Collaborators, 2003b)). 
Indeed, a developing country pattern of disease was observed amongst 
Pakistanis resident in a developed country, with high incidence in infants and 
young children and little disease in adulthood. This suggests community-
specific routes of transmission and accompanying disease burden, 
necessitating studies to identify risk factors for infection specific to this 
community, or to assess alternative explanations for these observations (e.g. 
use of healthcare facilities, prior immunity in older children, adults etc). 
 
Several methodological issues were identified in this study which warrant 
comment. Firstly, data from the 2001 census was unavailable at the time of 
the study, so ethnicity-specific denominator data from the 1991 census was 
used, and therefore the numerator and denominator differed by eleven years. 
It is possible, therefore, that the observed differences in risk might relate to 
changes in underlying population structure in the intervening period. This was 
considered unlikely as such changes would not explain the clinical, 
demographic, seasonal and exposure characteristics distinct to Pakistani 
cases. Secondly, we elected to ask patients to describe their ethnic origin 
rather than providing a choice of categories, meaning that for over a tenth of 
patients a description was not provided or was not classifiable.  This could 
have skewed our findings if certain ethnic groups were more or less likely to 
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proffer a description of their ethnic origin. Future studies should take such 
potential shortfalls into consideration. 
 
7.6 Patient exposure history in relation to the weekly periodicity of 
Campylobacter jejuni infection. 
 
The seasonality of Campylobacter infection in the UK is well described and is 
noted for the annual sharp increase in incidence which occurs consistently in 
late spring/early summer.  The pattern of infection over shorter time periods 
had not been investigated previously.  Accordingly, the day of onset for 5606 
UK-acquired cases of C. jejuni infection reported in the first two years of the 
study was calculated and examined (paper 6 (Gillespie et al., 2005)).   
 
Disease incidence was greatest on the days during or immediately following 
the weekend and cases who were ill at this time (N=3438) were more likely to 
have consumed Halal meats, offal, restaurant food or water from a private 
supply than cases whose illness onset occurred later in the week (N=2168).  
Furthermore, compared with those who had not eaten in restaurants, cases 
with a „weekend illness‟ were more likely to have consumed foods from 
takeaway kebab shops and Indian restaurants.  
 
It is tempting to conclude that, given the usual incubation period for 
Campylobacter infection, cases with illness onset at the weekend or soon 
after would have been exposed towards the end of the previous week. 
However, the incubation period for Campylobacter infection is thought to be 
inversely proportional to dose, and therefore the consumption of potentially 
heavily contaminated (e.g. offal or Halal meats) foods or untreated or poorly 
treated water might precipitate illness soon after.  To our knowledge this is 
the first time that the weekly periodicity of an infection has been studied.  The 
findings suggest that individuals undertake activities at the weekends which 
affect their risk of Campylobacter infection. Such potential daily differences in 
exposure should be considered when designing case-control studies of 
Campylobacter infection, as interviewing cases and controls on different days 
will increase the likelihood of differential recall bias.  This method could also 
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provide useful insights into the epidemiology of other infections, and not just 
those causing gastrointestinal illness. 
 
7.7 Host susceptibility and exposure history in relation to clinical 
presentation for indigenously-acquired Campylobacter jejuni infection. 
 
Human infection with campylobacter presents usually as an acute enteritis.  
Diarrhoea, malaise, fever and abdominal pain are the most commonly 
reported symptoms.  However, whilst nausea is common with Campylobacter 
infection, vomiting is less so. A case-case comparison was undertaken to 
examine host, microbiological and environmental factors which might give 
rise to this particular clinical manifestation in UK-acquired cases of C. jejuni 
infection (paper 7 (Gillespie et al., 2006)).  Bloody diarrhoea was studied in 
the same way as it was reported at a similar frequency as vomiting.   
 
Initially, UK-acquired cases from the entire study who reported vomiting 
(N=3346; 35.8%) and bloody diarrhoea (N=2661; 28.5%) were compared 
separately with cases who reported neither symptom (N=3335). However, it 
became apparent that these two manifestations were linked, since cases who 
reported one were more likely to experience the other.  Separate analyses 
revealed similar levels of morbidity (length of illness and hospital admission) 
and a similar risk exposure profile, hence cases who reported either 
symptom (N=4043) were compared with those who reported neither.  Cases 
who did not respond to one or both of these symptom questions (N=1972) 
were excluded from the analysis.   
 
Cases who reported vomiting and/or bloody diarrhoea were more likely to 
experience a longer illness and to be admitted to hospital than cases who 
reported neither.  Self-reported vomiting and/or bloody diarrhoea was more 
common amongst females but decreased with age.  It was more commonly 
reported by cases who reported the consumption of poultry other than 
chicken, pre-packed sandwiches or sausages, or amongst cases who 
reported engineering work on, or supply problems with, their water supply.  
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Similarly those who reported an increasing daily consumption of unboiled tap 
water were more likely to present with diarrhoea and vomiting. Eating salads, 
cheese and fish/shellfish was reported less commonly by cases reporting 
vomiting and/or bloody diarrhoea, and few associations with infecting C. 
jejuni serotype were observed. 
 
This study suggests that for Campylobacter infection, vomiting and bloody 
diarrhoea share a similar aetiology, represent the more severe end of the 
disease spectrum and might relate to host susceptibility and/or infective 
dose.  These findings have important implications for case-control studies of 
laboratory-confirmed Campylobacter infection.  If heavily contaminated (“high 
dose”) foods lead to severe disease then it follows that „normal‟ doses will 
lead to „normal‟ disease, „lower‟ doses will lead to mild symptoms that might 
be dismissed as disease and the lowest doses will lead to sub-clinical 
infections.  Some people will not be exposed at all (figure 5, below). 
  
 
Figure 5. An extension of the dose response model for Campylobacter 
infection and its hypothesised effect of case and control classification in 
case-control studies. 
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Cases in case-control studies of laboratory-confirmed infection will therefore 
consist of normal and severe infection (normal and high dose) whilst healthy 
controls will comprise individuals with very mild clinical (lower dose) or sub-
clinical (lowest dose) infections and those who were not exposed (no dose).  
Thus, case-control studies might be biased towards detecting high-dose 
foods.  An accurate assessment of the epidemiology of Campylobacter 
infection can therefore only be achieved whilst controlling for previous 
exposure to campylobacters in the control population. 
 
7.8 Demographic determinants for Campylobacter infection in England 
& Wales. 
 
In the final year of the study (May 2002 to April 2003), data from the 2001 UK 
census became available.  This provided an opportunity to address some of 
the methodological limitations experienced previously (paper 5 
(Campylobacter Sentinel Surveillance Scheme Collaborators, 2003a)), and to 
examine in detail the role of other demographic determinants in 
Campylobacter infection in England and Wales (paper 8 (Gillespie et al., 
2008)).  Cases who reported no history of foreign travel in the two weeks 
preceding their illness were studied (N=15,907). Cases‟ descriptions of their 
ethnic origins and occupations were classified according to the UK census 
classification and Standard Occupational Classification (SOC) 2000 
classification respectively. 
 
Overall, incidence was highest in infants, decreased from two to thirteen 
years, increased from 14 to 22 years and remained relatively stable from 22 
to 69 years before declining from 70 years.  This pattern varied with gender.  
Incidence was higher in males than females from birth to 17 years and this 
difference was most noticeable between 13 and 15 years. Gender-specific 
incidence then switched, with females at greater risk from 20 to 36 years. 
Greater variability was observed further up the age spectrum although 
overall, incidence was higher in males.  Analysis by ethnic group confirmed 
and extended earlier findings, demonstrating that the increased incidence in 
resident Pakistanis was not an artefact of dated denominator data, and that 
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the incidence in male Pakistani children under five years greatly exceeded 
that in female Pakistanis in the same age group, and in all other children in 
that age group, regardless of gender.  White-collar workers were at 
marginally greater risk of infection than blue-collar workers, and incidence by 
socioeconomic status varied greatly with age and gender. 
 
This study has reemphasized that age and gender are major determinants for 
Campylobacter infection in England and Wales and has also demonstrated 
that ethnicity, occupation and socioeconomic status are important. 
Epidemiological studies on Campylobacter infection need to take all these 
factors into consideration at either the design or the analysis stage if 
meaningful findings are to be obtained, and this is likely to increase either 
their size (larger single studies) or complexity (numerous smaller studies), 
with obvious financial implications. Some important hypotheses concerning 
the role of host susceptibility in disease transmission were also generated, in 
that we suggest that endogenous or exogenous hormones, present at 
elevated levels in different genders at different stages of life, might affect the 
growth characteristics of any campylobacters present in vivo, altering disease 
risk accordingly. 
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8. Discussion. 
 
 
The research carried out by the candidate and documented in the 
aforedescribed publications which form this body of work demonstrate that 
the aims and objectives of this project have been met. The candidate has 
successfully improved current understanding of Campylobacter infection and 
generated new hypotheses for infection.   
 
The candidate has demonstrated that age, gender, ethnicity, occupation and 
socioeconomic status are major determinants for Campylobacter infection in 
England and Wales, and that variation in behaviour throughout the week also 
has a bearing on risk.  The candidate has shown that campylobacteriosis 
cannot be considered a single disease, as exposure differences exist in 
cases infected with different Campylobacter species or subspecies, and 
these differences can be confounded by foreign travel status. The fact that 
disease incidence amongst foreign travellers is country-specific suggests that 
the above exposure differences will be confounded further by travel 
destination. The candidate has shown that outbreaks of campylobacteriosis 
occur more commonly than described previously, suggesting that an 
opportunity for furthering our understanding of infection is being missed. 
Finally, the candidate has examined the dose-response relationship for 
Campylobacter infection. 
 
A good marker for the significance of scientific work is its acceptance by 
peers. In addition to passing the peer-review process in journals with an 
average impact factor of 2.76, the publications which form this submission 
have been cited on sixty-six occasions by colleagues worldwide (table 4).  In 
addition, the data generated from the study has been used to answer over 50 
documented and many more undocumented information requests from 
Government, industry and academia.  It has contributed to at least three 
Government-funded research projects, has been used to inform World Health 
Organisation strategy on campylobacteriosis and has been presented at 
local, national and international meetings. 
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Table 4. Subsequent citation of the publications in this body of work 
(excludes self-citation). 
 
Paper Citation 
1 Tam et al., 2003; Evans, Ribeiro, & Salmon, 2003; Best et al., 
2003; Altekruse & Tollefson, 2003; Hopkins et al., 2004; Best et 
al., 2004; Siemer et al. 2004; Mangen, Havelaar, & de Wit, 2004;  
Miller et al., 2004; Nichols, 2005; Bae et al., 2005;  French et al., 
2005; Siemer, Nielsen, & On, 2005; Gurtler et al., 2005; Miller et 
al., 2005; Kolackova & Karpiskova, 2005;  Smole Možina & 
Uzunovic-Kamberovic, 2005; Wilson, 2005;  Miller et al., 2006; 
Tam et al., 2006a; Gilpin et al., 2006;  Tam, O'Brien, & 
Rodrigues, 2006; Black, Kirk, & Millard, 2006; Pennington, 2006; 
Workman et al., 2006; Samie et al., 2007; D'lima et al., 2007; 
Litrup, Torpdahl, & Nielsen, 2007; O'Brien & Halder, 2007; 
Karenlampi et al., 2007; Horrocks et al., 2007; Stafford et al., 
2007; Best et al., 2007; Chan et al., 2007; Blanco et al., 2007; 
Strachan et al., 2007 
2 Adak et al.. 2005; Cheng, McDonald, & Thielman., 2005;  Gurtler 
et al., 2005; Wilson, 2005; Alter & Scherer, 2006; Heaton & 
Jones, 2007; Álvarez, Estrada Lorenzo, & Pérez, 2007; Fussing 
et al., 2007; Evers, Horneman, & Doorduyn, 2007; Luquero 
Alcalde et al., 2007; Best et al., 2007 
3 Sopwith et al., 2006 
4 Osterlund, Hermann, & Kahlmeter, 2003; French et al., 2005; 
Humphrey et al., 2005; Uzoigwe, 2005; Rosenbaum, 2005; 
Wassenaar, Kist, & de Jong, 2007; Johnson et al., 2007; O'Brien 
& Halder, 2007;  Vicente et al., 2008 
5 - 
6 Nelson & Harris, 2006; Hanel & Atanassova, 2007 
7 Yip, 2007 
8 N/A in press 
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The sentinel health authorities were chosen for their geographical 
representativeness, with the hope that representation from each of the NHS 
regions in existence at the time would provide a study population broadly 
representative of England and Wales as a whole. A number of subtle 
differences were identified above, however, and these should be considered 
in terms of their potential bearing on the published findings. The sentinel 
health authorities contained a greater proportion of dense urban areas than 
England and Wales as a whole. It is probable that this contributed to the 
slight excess of Indian and Pakistani communities in the study population, as 
large cities often have greater populations of individuals from ethnic 
minorities. These variations in distal measurements would have little effect on 
the results of case-case analyses, however, as these focus on the effect of 
proximal measurements on disease risk. Furthermore they would have no 
effect on the disease determinant analyses, as the denominator used was 
particular to the sentinel health authorities and so controlled for any 
underlying population differences.  Conversely, the observed variations in 
response to the questionnaire by age group (slightly lower in young adults; 
slightly higher in older adults and the elderly) had the potential to affect the 
findings of paper 8 (Gillespie et al., 2008) in that incidence estimates by age 
would be biased downwards and upwards respectively for these age groups. 
This is based on the assumption, however, that all the isolates referred were 
from sentinel health authority residents, and this is unlikely for the reasons 
outlined previously. 
 
A critique of the suitability of the methods chosen for analysis and their 
application is also necessary, as is discussion of alternative strategies and 
their suitability. Exposure information for the fourteen day period prior to 
patients‟ onset of illness was captured, despite a mean incubation period for 
Campylobacter infection of three days and an upper range of approximately 
eight days. This period was chosen to ensure that all potential disease 
exposure events for as many patients as possible were captured, as the 
potential existed for exposures at the outer limit of the incubation period to be 
important, or for the incubation period to be underestimated. In doing so the 
prevalence of exposure to the proximal variables under investigation will 
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have been increased, necessitating additional statistical power to identify true 
differences which might have existed. However, data were captured on 
almost 20,000 cases of Campylobacter infection and therefore statistical 
power will have been adequate. 
 
The choice of denominator data in disease determinant analysis is important 
in ensuring that incidence estimates are not skewed. This is best illustrated in 
paper 3 (Campylobacter Sentinel Surveillance Scheme Collaborators, 
2003b), where the risk of campylobacteriosis associated with travel to 
Cumbria was inflated potentially by increased access to this area of the 
country by a number of participating health authorities situated in north or 
north west England. This was unavoidable, as health authority-specific 
denominator data was unavailable. It is important to bring such caveats to the 
attention of the reader so as to keep the findings in context. 
 
In paper 5 (Campylobacter Sentinel Surveillance Scheme Collaborators, 
2003a) and paper 8 (Gillespie et al., 2008) we were unable to control for all 
the factors under investigation in a single analysis, increasing the likelihood 
of uncontrolled confounding. This was especially apparent in the latter, where 
age, gender, ethnicity and socio-economic status were all investigated. This 
potential drawback could have been overcome by applying, for example, 
multivariate log-linked Poisson regression techniques to the data, which 
would also have allowed for the highly seasonal pattern of infection to be 
examined. Such techniques require denominator data stratified by all factors 
under investigation, however, and these were unavailable. 
 
Bearing in mind its advantages and disadvantages, case-case methodology 
is applicable to any data where an outcome is readily identifiable and 
exposure data are available, from whence they follow case-control study 
methodology. That is not to say however, that the analytical methods 
employed in the publications described were not improved over the course of 
the study. The changing analytical strategy with regard to the case-case 
comparisons, described previously, is a case in point.  However, there is no 
suggestion that the findings of the earlier studies are necessarily 
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fundamentally flawed. Since the application of case-case methodology to 
infectious disease epidemiology is in its infancy, no consensus on a gold-
standard method for analysis exists currently. It is hoped that the 
methodological advances detailed in these studies will inform future case-
case studies. 
 
Case-crossover studies are an alternative approach which could have been 
applied at the outset of this study (McCarthy & Giesecke, 1999). These 
involve capturing information on patients exposures in the incubation period 
for a particular disease and comparing these to exposures from a time 
outside the incubation period. They therefore employ „control times‟ rather 
than „control persons‟ with the patient perfectly matched to themselves. They 
obviate the need for ethical approval if conducted within a primary 
surveillance framework and are relatively simple to conduct. Ideal in theory.  
 
They assume, however, that the individual has done something „out of the 
ordinary‟ which has resulted in their disease episode and this assumption is 
debatable for Campylobacter infection. Whilst there are documented 
instances where a „change from the norm‟ has resulted in campylobacteriosis 
(e.g. household illness following the introduction of a puppy) it is equally 
possible that infection occurs as a result of indirect actions in everyday life 
(e.g. buying a contaminated sandwich from a sandwich shop where one 
routinely buys the same sandwich which has not previously been 
contaminated). Furthermore, the incubation period for Campylobacter 
infection would impact on the suitability of this study design. Firstly, it is long 
and therefore the control period would have to be some time prior to onset, 
increasing the likelihood of recall bias for the „control‟ over the „case‟ period. 
Secondly, it is variable, and therefore if the chosen control period is too 
recent then it is possible that the illness-causing exposure could be included 
in the control period and hence the case would be misclassified as a control. 
 
In the absence of a control group, descriptive studies can only tell us so 
much about the role of particular exposures in disease, and policy makers 
and public health practitioners generally require a higher level of evidence for 
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action. In the absence of improvements in the detection of outbreaks of 
Campylobacter infection, it is likely that case-control studies will remain the 
epidemiological tool of choice for the foreseeable future. Perhaps the 
greatest contribution of this body of work, therefore, is that it informs greatly 
on the conduct of future case-control studies of Campylobacter infection. 
Unless travel-associated infection is under investigation, studies should be 
restricted to domestically-acquired cases and consideration should be given 
to restricting further to cases who have not travelled within the UK prior to 
illness. Studies should be conducted at the Campylobacter species level, or 
better still sub-species level. Studies should be restricted to, or matched on, 
age, gender, social and ethnic group, and these factors should also be 
investigated during analysis. Perhaps most fundamentally, the exposure 
status of controls needs to be measured immunogenically to determine if 
they are in fact controls, or merely unidentified cases. Controls should also 
be interviewed on the same day of the week as the case‟s onset date and 
with the minimum delay between case and control interviews (i.e. a week). 
Finally, investigators must approach studies with open minds, rather than 
focussing on chicken as a source of infection. 
 
For these requirements to be met, case-control studies of Campylobacter 
infection will need to be larger and more complex, with obvious financial 
implications. Policy makers should bear this in mind when commissioning 
research into the study of risk factors for Campylobacter infection. The 
provision of greater resources for either larger or more focused studies 
should result in more accurate findings, leading to the opportunity for more 
evidence-based policy development. In the immediate term, policy makers 
should commission research to investigate the high disease incidence in the 
resident UK Pakistani community. 
 
The body of work also identifies additional areas for research. A rapid and 
non-invasive method of assessing accurately previous exposure to 
campylobacters amongst healthy controls is a research priority as it will 
enable researchers to distinguish true controls from undiagnosed cases, 
leading to increased specificity when defining the study outcome in case-
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control studies. The potential role of drinking water (both bottled and 
municipal) in campylobacteriosis was highlighted in a number of the 
published works, and therefore research is required to improve the methods 
for the isolation of campylobacters from water, leading to a detailed 
assessment of the prevalence of, and hence the potential risk from, 
campylobacters in drinking waters. Outbreaks of campylobacteriosis appear 
to be underascertained and therefore a system should be developed which 
routinely detects and reports clusters of infection to local investigators. This 
would require not only the agreement of a minimum dataset (onset date, 
postcode and foreign travel status (for exclusion purposes) should suffice) to 
define clusters in time and space, but also a change to current 
public/environmental health practice, as the data collected would need to be 
entered into a single database for analysis. Finally, work should continue into 
the development of typing methods which are sufficiently robust so as to form 
epidemiologically-meaningful organism groups, whilst not being overly 
cumbersome or prohibitively expensive and hence are applicable to all 
campylobacters. 
 
In conclusion, campylobacters are a common cause of gastrointestinal 
disease in developed countries worldwide. The disease is not trivial and a 
number of sequelae add to the substantial disease burden. 
Campylobacteriosis-associated death, whilst rare, appears to be 
underestimated. An improved understanding of the complex epidemiology of 
Campylobacter infection is therefore an essential first step in informing on 
prevention strategies. This study has demonstrated that the systematic 
collection of standardised epidemiological information on all cases of 
Campylobacter infection, reported from large, well defined populations over 
prolonged periods, coupled with detailed strain characterisation, can achieve 
this, leading to public health gains. 
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Appendix 1. 
The history of the discovery of campylobacters as major 
gastrointestinal pathogens. 
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Table A1.1: Notable events in the history of campylobacters. 
 
Year Human medicine Veterinary medicine 
1886 Theodore Escherich describes spiral 
bacteria in intestinal mucus in 16 of 17 
children who had died of „cholera 
infantum‟. Spiral bacteria also observed 
in 35 of 72 children suffering from enteric 
disease. Presence thought prognostic 
rather than causative. (Kist, 1985) 
Escherich observes spiral, curved non-
culturable bacteria in the faeces of 
kittens which died of diarrhoeal disease. 
Terms these bacteria Vibrio felinus. (Kist, 
1985) 
1887 Pfeiffer observes spiral bacteria in the 
large intestine of a nun who had died of a 
disease resembling campylobacter 
colitis. He wrongly concludes that gut 
inflammation had produced conditions 
favourable for Vibrio cholera to develop 
spiral forms. (Kist, 1985) 
 
1892 Fuerbringer observes spiral, curved, non-
culturable bacteria in the small intestine 
of a patient who died of severe cholera-
like disease. V. cholera not detected. 
(Kist, 1985) 
 
1893 Kowalski reports highly motile non-
culturable spirilla in 11 patients with 
“cholera” and two patients with “cholera-
like” disease. Similar observations 
published in 1894. (Kist, 1985) 
 
1906  McFadyean and Stockman isolate vibrios 
from the uterine mucus of a pregnant 
sheep from a flock experiencing an 
abortion rate of 33%. (Skirrow, 2006) 
1911  Vibrios isolated from cases of abortion in 
cattle in Ireland & Wales. (Smith, 1918) 
1913 Curtis notes curved, motile, anaerobic 
bacilli from a post-instrumental abortion 
and from a complicated labour. (Curtis, 
1913) 
 
1918  Theodore Smith isolates vibrios from the 
aborted foetal tissue of 14 cattle negative 
for Bacillus abortus (now Brucella 
abortus). Describes growth requirements, 
investigates pathogenicity and 
demonstrates antigenic similarity. Names 
the organism Vibrio fetus. (Smith, 
1918;Smith, 1919;Smith, 1923;Smith, 
Little, & Taylor, 1920;Smith & Taylor, 
1919) 
1931  Jones and Little isolate „tiny motile 
vibrios‟ from the intestines of cattle and 
calves suffering from epidemic winter 
scouring, establish infectivity and exclude 
a dietary cause. Demonstrate antigenic 
differences from V. fetus and propose the 
name Vibrio jejuni after isolation from 
ulcers in the jejunum. (Jones & Little, 
1931) 
1944  Doyle isolates vibrios from the colon of 
pigs suffering from Swine dysentery and 
demonstrates pathogenicity. (Doyle, 
1944) 
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Year Human medicine Veterinary medicine 
1947 Vinzent grows V. fetus from the blood of 
three pregnant women. Suspects 
milkborne transmission. (Vinzent, 
Dumas, & Picard, 1947) 
 
1948 Levy describes the isolation of vibrios 
from the blood of 47 cases in a milkborne 
outbreak of gastroenteritis affecting 357 
inmates in two prisons in the USA. The 
organism „bore a close resemblance‟ to 
V. jejuni. (Levy, 1928) 
 
 Ward describes a mild V. fetus human 
laboratory infection (cheek pustule). 
(Ward, 1948) 
 
  Further observations on swine dysentery 
by Doyle. Organism named V. coli due to 
the site of infection. (Doyle, 1948) 
1949  Stegenga and Terpstra demonstrate the 
pathogenic role of V. fetus venerealis in 
enzootic sterility in cows. (Butzler, 2004) 
1957 Examining in detail 32 human and 13 veterinary vibrio isolates, King differentiates V. 
fetus strains from four „related vibrio‟ strains on cultural, biochemical, and serological 
characteristics and relates this to the symptomology and epidemiology of the infected 
patients. Infections with V. fetus occurred systemically in predisposed individuals 
whilst related vibrios occurred in infants and children with diarrhoea. With regard to 
the latter, she noted that chickens are known to have a disease caused by a similar, 
if not identical, organism. (King, 1957) 
1958  Peckham, Hofstad and co-workers 
isolate vibrios from the livers and 
gallbladders of chickens with „Vibrionic 
Avian Hepatitis‟. Strains biochemically 
indistinguishable from related vibrios. 
(Peckham, 1958) 
1959  Florent distinguishes Vibrio venerealis 
from Vibrio intestinalis. (Butzler, 2004) 
1961 Wheeler and Borchers describe four 
cases of „vibrionic enteritis‟ in infants. As 
an aside, a link between chicken and a 
„related vibrio‟ is described and an 
hypothesis of asymptomatic infections in 
adulthood due to childhood exposure is 
generated. (Wheeler & Borchers, 1961) 
 
1963 Sebald and Veron demonstrate that the DNA base composition of the microaerophilic 
vibrios differs from the cholera group, and suggest a new genus called 
Campylobacter. (Sebald & Veron, 1963) 
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Year Human medicine Veterinary medicine 
1972 Dekeyser applies successfully veterinary 
techniques to isolate related vibrios from 
the faeces of two patients with vibrionic 
enteritis. The organisms are 
biochemically and antigenically similar to 
each other and to an isolate from one 
patient‟s blood. Thirty five strains of 
related vibrios subsequently isolated 
from 1000 enterobacteriaceae-negative 
stool samples. (Dekeyser et al., 1972) 
 
1973 Butzler isolates related vibrios from 
41/800 (5%) and 4/100 (4%) of stools 
from children and adults with diarrhoea 
respectively, compared with 13 (1.3%) of 
1000 children without diarrhoea. (Butzler 
et al., 1973) 
 
1977 Skirrow repeats and extends Butzler‟s 
work. Demonstrates 57/803 (7.1%) 
patients with diarrhoea are infected with 
campylobacters compared with 0/194 
control patients. (Skirrow, 1977) 
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Appendix 2. 
An assessment of the role of campylobacters in reported  
mortality statistics in England and Wales. 
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Methods. 
 
The Health Protection Agency Centre for Infections maintains a database of 
all certified deaths, reported to the Office for National Statistics, where an 
infection was recorded as the certified underlying or contributory cause of 
death. These represent approximately 10-15% of all deaths reported 
annually. Descriptions of the underlying or contributory causes are provided, 
in addition to their relevant International Classification of Diseases (ICD) 
coding (ICD-9 from 1993-2000 and ICD-10 from 2001 to 2006). 
 
Deaths with any link to campylobacters were identified by searching the 
accompanying text fields for instances of „camp*‟. For deaths reported from 
2001 to 2006 those attributed directly to campylobacters were identified 
where the underlying cause field was coded as A045 („Campylobacter 
enteritis‟). For deaths from 1993-2000 only the first four digits of the death 
codes were available, and therefore campylobacter deaths (ICD-9 code 
008.43) were coded as 008.4 („Intestinal infections due to other specified 
bacteria‟). Accordingly, campylobacters were assigned as the underlying 
cause for those deaths where the underlying cause was coded as 008.4 and 
campylobacters were the only infectious agent recorded. 
 
Data on all cases of campylobacteriosis reported to the Health Protection 
Agency between 1993 and 2007 were extracted from the national laboratory 
database to act as a denominator data for the calculation of case fatality 
rates. Relative risks and 95% confidence intervals were calculated using 
Stata version 10 (Stata Corporation, 1999) and chi squared tests calculated 
using Epi Info (Dean et al., 1996). 
 
To assess which factors might lead to the underestimation of campylobacter-
associated mortality, a binary outcome variable was created to compare 
those deaths where campylobacter was not recorded as the underlying 
cause versus those where it was. Explanatory variables were created to 
represent ICD-9 or ICD-10 coding, gender, patients who were elderly or who 
had a recorded underlying condition. An additional variable was created to 
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compare the period after 2000 with previous years, as a rule change on the 
recording of pneumonia as an underlying cause was introduced at this time. 
A categorical variable was created to represent approximations of the 
seasons in which death occurred (Winter=December to February; 
Spring=March to May; Summer=June to August; Autumn=September to 
November). The effect of each explanatory variable on the outcome of 
interest was assessed using single variable logistic regression. Variables 
significantly associated with the outcome of interest at a level of 90% or 
higher were included in a multivariate logistic regression model, which was 
simplified subsequently using the likelihood ratio test with a P value cut-off of 
0.05. 
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Results. 
 
Between 1993 and 2006 campylobacters were recorded as the underlying 
cause of 45 deaths in England and Wales, giving an incidence of 6.6 deaths 
per 100,000 cases of infection (95% confidence interval (95%CI) 4.8-8.9) or a 
case fatality rate of 0.007% (95%CI 0.005%-0.009%). However, when all-
cause mortality was examined 153 deaths were identified, giving an 
incidence rate of 22.5 deaths per 100,000 infections (95%CI 19.1-26.3), or a 
case fatality rate of 0.022% (95%CI 0.018%-0.026%). Hence, underlying 
cause mortality underascertains the role of campylobacters by a factor 
greater than three (incidence ratio (IR) 0.29; 95%CI 0.21-0.41). Subsequent 
analysis relates to all-cause mortality unless stated otherwise. 
 
Campylobacter patients who died were often elderly (83/153; 54%) or had an 
underlying condition (most commonly cardiovascular conditions (37%) or 
malignancies (22%)). Over a quarter of patients fulfilled both criteria (43; 
28%). The case-fatality rate in those aged 70-79 years (0.12%; 95%CI 0.08-
0.16%) was higher than in those aged <70 years (0.005%; 95%CI 0.003-
0.007%), with the rate in those over 80 years (0.49%; 95%CI 0.38-0.60%) 
higher still. Gender alone had no effect on mortality (RR 1.07; 95%CI 0.78-
1.46), although mortality was higher in males than females between 30 and 
69 years (RR 4.3; 95%CI 0.9-20.1), but not in older age groups (RR 1.0; 
95%CI 0.7-1.4; figure A2.1). 
 
Campylobacteriosis-associated all-cause mortality was higher in winter 
months (December to February) compared with the rest of the year (RR 2.31; 
95%CI 1.65-3.23; figure A2.2). Cases who died in the winter months were no 
more likely to be elderly (86% vs. 81%; 2 P=0.5), male (45% vs. 55%; 2 
P=0.3) or have a reported underlying condition (55% vs. 54%) than cases 
who died at other times of the year. 
 
Factors leading to the underestimation of the role of campylobacter in 
reported mortality are shown in table A2.1. Of the parameters under 
investigation by single variable analysis, only the presence of an underlying 
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condition was significantly associated with underestimation of the role of 
campylobacters in all-cause mortality. This association remained when 
logistic regression analysis, controlling for ICD coding, season and gender, 
was applied (Odds Ratio (OR) 2.3; 95%CI 1.1-4.6; P=0.03). In addition, 
campylobacter-associated all cause mortality was independently more likely 
to be underestimated in patients aged 80 years and over compared to those 
under 60 years (OR 3.2; 95%CI 1.1-9.2; P=0.03). 
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Conclusions. 
 
 Underlying cause mortality statistics underestimate the role of 
campylobacters by a factor of more than three, and this 
underestimation is greatest where the patient is either very old or has 
another known underlying condition. Hence the overall disease burden 
of Campylobacter infection is greater than current estimates suggest. 
 
 Nevertheless, campylobacter-associated all-cause mortality is rare in 
England and Wales in comparison to other common gastrointestinal 
pathogens, with a case-fatality rate of only 0.02%.  
 
 Campylobacter-associated all-cause mortality appears to be 
dependent on age, gender and season.
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Figure A2.1: All-cause campylobacter-associated mortality by age 
group and gender. England and Wales, 1993-2006. 
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Figure A2.2: All-cause campylobacter-associated mortality by month. 
England and Wales, 1993-2006. 
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Table A2.1: Factors affecting the underestimation of the role of 
campylobacters in campylobacter-linked all-cause mortality. England and 
Wales, 1993-2006. 
 
Parameter 
Deaths 
Odds 
Ratio 
95% CI‡ P 
value 
Non-
Campy* 
Campy† 
Lower Upper 
       <59 years 8 15 1.0 - - - 
60-69 years 6 5 2.3 0.5 10.2 0.28 
70-79 years 22 20 2.1 0.7 6.0 0.18 
80+ years 43 34 2.4 0.9 6.4 0.08 
       
Non-elderly (<65 years) 11 15 1.0 - - - 
Elderly (≥65 years) 68 59 1.6 0.7 3.7 0.30 
       
Female gender 36 38 1.0 - - - 
Male gender 43 36 0.8 0.4 1.5 0.48 
       
ICD-10 38 27 1.0 - - - 
ICD-9 41 47 1.6 0.8 3.1 0.15 
       
No underlying condition 50 33 1.0 - - - 
Underlying condition 29 41 2.1 1.1 4.2 0.02 
       
Winter 25 26 1.0 - - - 
Spring 19 13 1.5 0.6 3.8 0.36 
Summer 23 23 1.0 0.5 2.3 0.92 
Autumn 12 12 1.0 0.4 2.8 0.94 
*, All-cause mortality linked to campylobacters where campylobacteriosis was not recorded 
as the underlying cause; 
†
, All-cause mortality linked to campylobacters where 
campylobacteriosis was recorded as the underlying cause; 
‡
, Confidence Interval 
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Appendix 3. 
An analytical review of published case-control studies of 
sporadic Campylobacter infection 
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Methods. 
 
The PubMed database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) was 
interrogated to identify citations which contained the Medical Subject 
Heading (MeSH) term “Campylobacter” or the text word “Campylobacter” and 
which also contained the MeSH term, MeSH subheading or text word 
"Epidemiology", but where no fields in the database contained “periodontal” 
or “pylori”. The latter statements were included to exclude manuscripts 
relating to campylobacters as a cause of periodontal disease (e.g. 
Campylobacter rectus) and articles relating to Helicobacter pylori, which was 
originally termed Campylobacter pylori. The search results were then limited 
to English language articles relating to human subjects. 
 
The titles and abstracts for the resulting citations were then scrutinized and 
potential case-control studies on sporadic human Campylobacter infection, 
undertaken in developed countries, were identified. Manuscripts were 
obtained, read, assessed and categorised. Reference lists were inspected in 
order to identify additional studies not found through the PubMed search.  
Salient epidemiological characteristics of the investigation and findings were 
stored in a bespoke Microsoft Access database.  
 
Simple statistical analyses of the resulting data were undertaken using 
Microsoft Excel.  Frequencies, percentages and means were calculated 
where required.  Stata version 10 (Stata Corporation, 1999) was used to 
assess factors affecting the number of reported risk factors for infection 
identified in case-control studies. Three categorical variables were created. 
One compared studies conducted in the eighties with those conducted in the 
nineties and those conducted from 2000. A second compared studies 
conducted in North America with those conducted in the United Kingdom, 
those conducted in the rest of Europe and those conducted in Australasia. 
The third compared studies of less than one year duration with those lasting 
12 months and with those lasting longer than 12 months. Binary variables 
were created to compare those studies where multivariate techniques were 
applied with those where they were not and to compare those studies limited 
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to indigenously acquired infection with those which included all cases. For 
each continuous variable (the number of risk factors identified; number of 
cases included; number of controls included; number of variables 
investigated; the exposure period in days, the overall study sample size; the 
ratio of cases to controls) Stata‟s „ladder‟ command was used to determine 
the transformation which best converted that variable into a normally or near-
normally distributed variable, then that transformation was performed on that 
variable. 
 
The effect of each of these variables on the outcome of interest (the 
transformed number of reported risk factors) was investigated initially using 
single variable Poisson regression. Variables significantly associated with the 
outcome of interest at or above the 90% level were then included in a 
multiple variable Poisson regression model which was simplified using the 
likelihood ratio test. 
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Results. 
 
Initially, 1734 articles were identified through a search of PubMed undertaken 
on the 23rd September 2007, which gave rise to 36 potential articles on case-
control studies on sporadic human Campylobacter infection in developed 
countries (Murray, 1986; Deming et al., 1987; Southern, Smith, & Palmer, 
1990; Hudson et al., 1990; Lighton, Kaczmarski, & Jones, 1991; Hudson et 
al., 1991; Kapperud et al., 1992; McElroy & Smyth, 1993; Ikram et al., 1994; 
Schorr et al., 1994; Neal & Slack, 1995; Adak et al., 1995; Neal et al., 1996; 
Eberhart-Phillips et al., 1997; Neal & Slack, 1997; Svenungsson et al., 2000; 
Studahl & Andersson, 2000; Effler et al., 2001; Rodrigues et al., 2001; 
Tenkate & Stafford, 2001; Smith et al., 2002; Neimann et al., 2003; Kapperud 
et al., 2003; Potter, Kaneene, & Hall, 2003; Evans, Ribeiro, & Salmon, 2003; 
Cameron et al., 2004; Friedman et al., 2004; Engberg et al., 2004; 
Schonberg-Norio et al., 2004; Michaud, Menard, & Arbeit, 2004; Carrique-
Mas et al., 2005; Olesen et al., 2005; Baker et al., 2005; Ethelberg et al., 
2005; Wingstrand et al., 2006; Fullerton et al., 2007). A further 27 articles 
were identified through the reference lists of these papers (Pearson et al., 
1977; Bruce, Zochowski, & Ferguson, 1977; Blaser & Reller, 1981; Norkrans 
& Svedhem, 1982; Kist, 1982; Severin, 1982; Taylor et al., 1983; Hopkins & 
Scott, 1983; Blaser, Taylor, & Feldman, 1983; Santosham et al., 1983; Potter 
et al., 1983; Kist, 1983; Oosterom et al., 1983; Hopkins, Olmsted, & Istre, 
1984; Oosterom et al., 1984; Engleberg et al., 1984; Nolan, Harris, & 
Canova, 1984; Hopkins & Olmsted, 1985; Kist & Rossner, 1985a; Harris, 
Weiss, & Nolan, 1986; Harris et al., 1986; Harris, Weiss, & Thompson, 1986; 
Salfield & Pugh, 1987; Schmid et al., 1987; Harris et al., 1987; Saeed, Harris, 
& DiGiacomo, 1993; Kassenborg et al., 2004), giving 63 articles in total. 
Scrutiny of the manuscripts revealed that eight were not case-control studies 
(Pearson A et al., 1977; Bruce, Zochowski, & Ferguson, 1977; Norkrans & 
Svedhem, 1982; Hopkins & Olmsted, 1985; Hudson et al., 1990; 
Svenungsson et al., 2000; Engberg et al., 2004; Olesen et al., 2005), four 
were case-case comparisons (Murray, 1986; Neal & Slack, 1995; Evans, 
Ribeiro, & Salmon, 2003; Kassenborg et al., 2004), three were non-exposure 
case-control studies (one examined the role of various drugs on patient 
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susceptibility to Campylobacter infection (Neal, Scott, Slack, & Logan, 1996), 
one examined the impact of Campylobacter infection on health and health-
related behaviour (Smith et al., 2002), and one examined demographic and 
geographic parameters in relation to Campylobacter infection (Ethelberg et 
al.. 2005), three described case-control studies in detail too scant to 
contribute meaningfully to understanding (Santosham et al., 1983; Kist 1983; 
Baker et al., 2005), two were review articles (Blaser & Reller, 1981; Blaser, 
Taylor, & Feldman, 1983), two described outbreaks of Campylobacter 
infection (Potter et al., 1983; Harris et al., 1987), two were reports which went 
on to peer-reviewed publications already included  (Oosterom et al., 1983; 
Nolan, Harris, & Canova, 1984) and one focussed on factors which reduce 
the risk of Campylobacter infection (Cameron, et al., 2004). One manuscript 
(Harris, Weiss, & Thompson, 1986) cited in another (Saeed, Harris, & 
DiGiacomo, 1993) did not exist. These papers were excluded, and three 
papers (Harris, Weiss, & Nolan, 1986; Harris et al., 1986; Saeed, Harris, & 
DiGiacomo, 1993) reporting different aspects of the same study were 
combined into a single record, leaving 35 studies for analysis. 
 
Twelve studies were published in the 1980s, ten in the 1990s and thirteen to 
date this decade, with most studies conducted in North America, the United 
Kingdom (UK) and the rest of Europe in each of these decades respectively 
(table A3.1). Studies were most frequently conducted over twelve months on 
subjects from all age groups, but some were restricted to adults or 
infants/children. The average number of study participants increased over the 
surveillance period, with the number of parameters under investigation 
increasing commensurately. Studies increasingly focused on indigenously-
acquired infections, employed matching in control selection and utilised 
multivariate statistical techniques in analysis.  Surprisingly, the period of 
exposure for which information was sought did not vary greatly, averaging 
nine days. 
 
Based on the information reported, most studies asked participants about 
recent exposure to poultry (especially chicken) or dairy produce, as well as 
foreign travel and contact with animals and the wider environment. A 
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disproportionately high number of questions on poultry and/or chicken 
consumption were included compared with other meat types, and the number 
of poultry-related questions posed increased over the surveillance period. 
The number of reported questions on selected epidemiological parameters, 
reported in each study, is provided in table A3.2. 
 
General poultry consumption was the most commonly identified risk factor, 
with three quarters (75%) of studies reporting this exposure where it was 
investigated, followed by animal contact (48%), water consumption (48%), 
dairy consumption (46%) and foreign travel (non-indigenous studies; 44%). 
Where investigated, chicken consumption was the most commonly identified 
specific exposure (58%), and the number of specific chicken risk factors 
reported (26) was exactly double the second most commonly reported 
specific risk factor (contact with animals other than dogs; 13; table A3.3). 
Other specific risk factors identified included the consumption of 
unpasteurised milk (47%), barbecued food (44%) or raw water (44%), and 
contact with dogs (42%). No case-control studies identified beef or pork as a 
risk factor for Campylobacter infection. 
 
Population Attributable Fractions are estimates of the proportion of disease in 
the general population that is attributable to a particular risk factor. Where 
reported (seven studies; table A3.4), chicken accounted for between 0 and 
24% of campylobacter cases, and an average of 12% of cases. 
 
On average, four risk factors were identified in each study, with the number 
of factors ranging from one to twenty. Single variable Poisson regression 
analysis revealed that the number of risk factors identified in studies was 
unaffected by the decade in which it was undertaken, the area covered, or 
the duration of the study. Limiting studies to indigenous cases, altering the 
exposure period, or applying multivariate statistical techniques in analysis 
similarly had no effect. However, the number of reported risk factors 
identified in studies was positively influenced by the number of cases or 
controls included in the study (and hence the overall study size), and the 
number of variables considered. Multivariable analysis controlling for study 
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year demonstrated that only the number of controls included (RR 1.42; 
95%CI 1.03-1.94; P=0.031) and the number of variables investigated (RR 
1.33; 95%CI 1.00-1.77; P=0.048) were independently associated with the 
number of risk factors identified. 
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Conclusions. 
 
 Case-control studies of Campylobacter infection are increasing in size 
and complexity without the corresponding improvement in our 
understanding of disease transmission.  
 
 The move towards larger studies are perhaps magnifying the biases 
inherent in the methodology.  
 
 They appear to be influenced heavily by investigator and reporter bias, 
as evidenced by the disproportionate pursuit of the poultry hypothesis, 
which continues to explain only a fraction of cases, emphasising the 
need for more creative approaches to hypothesis generation.  
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Table A3.1 Reported epidemiological features in published case-control 
studies of sporadic Campylobacter infection. 
 
Factor 
Decade (N) 
Total 
80s (12) 90s (10) 00s (13) 
Publication area (%)     
 N America 58 0 38 34 
 Rest of Europe 33 20 46 34 
 UK 8 60 8 23 
 Australasia 0 20 8 9 
Study population     
 All 75 80 77 77 
 Adults 17 20 0 11 
 Infants & children 8 0 23 11 
Percentage indigenous 9 40 62 38 
Mean study length (months) 14 7 12 11 
Mean sample size 326 456 565 452 
Mean number of variables 19 32 106 55 
Mean exposure period 7 10 10 9 
Mean interview lag 10 10 14 11 
Percentage matching 83 100 100 94 
Percentage multivariate analysis 17 50 92 54 
Foreign travel†     
 % enquiry 60 83 100 76 
 % risk factor 33 33 50 39 
Poultry variables     
 % enquiry – any 75 80 85 80 
 % enquiry – ch* 58 70 77 69 
 Mean no. variables – any 4 9 10 8 
 Mean no. variables – ch* 4 6 8 6 
 % risk factor – any 89 63 73 75 
 % risk factor – ch* 86 43 50 58 
Other (non-poultry) meats     
 % enquiry 42 70 92 69 
 Mean no. variables 8 5 6 6 
 % risk factor 40 29 42 38 
Dairy     
 % enquiry 40 100 100 80 
 % risk factor 80 51 31 46 
Water      
 % enquiry 42 60 77 60 
 % risk factor 80 33 40 48 
Animal contact     
 % enquiry 42 60 77 60 
 % risk factor 80 33 40 48 
Total risk factors identified 44 41 55 140 
Mean risk factors identified 4 4 4 4 
†
, Excludes indigenous-only studies; *, chicken 
Table A3.2. Selected investigated exposures reported in published case-control studies of sporadic Campylobacter infection. 
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Foreign travel   1     1 1   1 1     1   1       1 1 1 1 1     1 1     1   1     1 1 
Restaurants   1     1                 2   4 1 1       2   1     1 1   7   2       
Poultry - all 1 2   2 6 1   1 18   2 7 3 3   16   24 5 4 15 3 4 11 8   24 11 1 40   7 1 3 1 
Poultry - chicken   2   2 5 1     10   2 6 3 3   2   13   4 14 1 4 10 8   16 3   36   1 1 1 1 
Beef   2       1     10       1     3 1   3     1   2     2 1 1 10         1 
Pork   2     1 1     10       1     2           1 4 3   3 3 1 1 8       1   
Lamb   2             1             2           1       1   1   1           
Other meat         1 1           1       7 3       1 3 5   1 1   7   3 1   1     
Barbecued food         1 1               1   1 1 7   5 1 1 1   1   2 2   2   1 1 1   
Fish and shellfish                 10     1       2   1 1     1     2     1   2 1         
Salad, vegetables 
and fruit 
        1       7   1         3     2   6       4 2 4 2   2       4 1 
Food hygiene 
practices 
            1   1   1         9   4       2 3   6 4 3     1   1     1 
Pasteurised milk                 7       7 6 4 1 1     1   2     1 2                   
Unpasteurised 
milk 
        1     1 4   1 1   1   1 1   1   1 1 1 1     1 1 1 1   1 1     
Other dairy         1     1 29             2 3 1 2   1 3 1     2       1 1     1 1 
Raw water     1   1   2   1   1     1   1   1 1 1 1     1 1     2   1     1     
Municipal water                           1       2   1         1   1 2     1   1 1 1 
Private water                                         3         1 1       1         
Contact with dogs 1 1       1     4 1 2 1 2     2   1     2 2 1 2 1 2   2   5     1     
Contact with other 
animals 
  8     1 4 10   12   3 3 2 2   10   2 1 2 10 6 4 1 2 8 5 8 29 16   1 9   1 
Environmental 
exposure 
        1   1   2   1   1 11 1 3   1 1 1 4 7 2     2   7 3 3 1   1 2 1 
Contact with other 
ill people 
1 1     2   1 1 3   1 4   1 1         1   3       1   1   1           
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Table A3.3 Selected reported risk factors in published case-control studies of sporadic Campylobacter infection. 
Parameter 
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Foreign travel               1 1                   1     1     1                 1 1 
Restaurants                                                               1       
Poultry - all 1 1   1 1 1   1 6     2       1   1 1   6 1 1 1 1   1 1   3   1   1   
Poultry - chicken   1   1 1 1     5     2           2     6 1 1 1 1         2       1   
Beef                                                                       
Pork           1                                 2         1               
Lamb                                                                       
Other meat                                         1       1         1 1         
Barbecued food           1                   1   2   1 1   1       1 1               
Fish and shellfish                 2                                         1           
Salad, vegetables 
and fruit 
                1                       1           1             1 1 
Food hygiene 
practices 
                1                                   1               1 
Pasteurised milk                         6 1 2             1                           
Unpasteurised 
milk 
        1     1 1   1                   1   1       1     1   1       
Other dairy                 1                                                     
Raw water     1   1   1   1                     1               1         1     
Municipal water                                                                 1   1 
Private water                                         1                   1         
Contact with dogs                 3 1           1         1 1       1       1     1     
Contact with other 
animals 
  1     1   1   1     1               1 1   1     1   1 1 1         1 
Environmental 
exposure 
                                            2             2 1       1 
Contact with other 
ill people 
  1           1 2   1                                                 
Table A3.4. Population Attributable Fractions for all risk factors and for 
chicken risk factors in published case-control studies of sporadic 
Campylobacter infection. 
 
Year All risk factors Chicken risk factors Reference 
1997 75 11 Eberhart-Phillips et al., 1997 
2001 20 11 Rodrigues et al., 2001 
2003 74 0 Neimann et al., 2003 
2004 77 24 Friedman et al., 2004 
2005 102 0 Carrique-Mas et al., 2005 
2006  -* 24 Wingstrand et al., 2006 
2007 114 12 Fullerton et al., 2007 
*, Not reported 
 171 
Table A3.5. The effect of various reported study features on the log-
transformed number of reported risk factors identified in published case-
control studies of sporadic Campylobacter infection. Single variable Poisson 
regression analysis. 
 
Parameter 
Relative 
risk 
95% CI† P 
value Lower Upper 
     Study decade:     
  - 80s 1 - -  - 
  - 90s 1.33 0.57 3.12 0.51 
  - 00s 1.50 0.68 3.28 0.32 
Area:     
  - North America 1 - -  - 
  - Rest of Europe 1.15 0.53 2.49 0.73 
  - United Kingdom 0.75 0.28 2.00 0.57 
  - Australasia 1.81 0.66 4.97 0.25 
Study period:     
  - 1-11 months 1 - -  - 
  - 12 months 1.49 0.68 3.27 0.33 
  - >12 months 1.47 0.68 3.16 0.33 
Indigenous cases vs. all cases 0.91 0.47 1.76 0.78 
Exposure period (days)* 0.68 0.00 195.02 0.89 
Multivariate vs. univariate analysis 1.32 0.68 2.54 0.41 
Cases‡ 1.40 1.04 1.88 0.03 
Controls‡ 1.47 1.10 1.96 0.01 
Cases : controls* 0.25 0.04 1.60 0.14 
Sample size‡ 3.25 2.60 4.07 0.00 
Variables‡ 1.37 1.07 1.76 0.01 
†
, Confidence Interval;*, reciprocal root transformed; 
‡
, log transformed 
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Appendix 4. 
The Campylobacter Sentinel Surveillance 
Scheme questionnaire. 
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